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ABSTRACT
An Engineering Approach Towards Personalized Cancer Therapy. (August 2009)
Golnaz Vahedi, B.S., Sharif University of Technology;
M.S., University of Alberta
Co–Chairs of Advisory Committee: Dr. Edward R. Dougherty
Dr. Jean-Francois Chamberland-Tremblay
Cells behave as complex systems with regulatory processes that make use of many ele-
ments such as switches based on thresholds, memory, feedback, error-checking, and other
components commonly encountered in electrical engineering. It is therefore not surprising
that these complex systems are amenable to study by engineering methods. A great deal
of effort has been spent on observing how cells store, modify, and use information. Still,
an understanding of how one uses this knowledge to exert control over cells within a living
organism is unavailable. Our prime objective is “Personalized Cancer Therapy” which is
based on characterizing the treatment for every individual cancer patient. Knowing how
one can systematically alter the behavior of an abnormal cancerous cell will lead towards
personalized cancer therapy. Towards this objective, it is required to construct a model for
the regulation of the cell and utilize this model to devise effective treatment strategies. The
proposed treatments will have to be validated experimentally, but selecting good treatment
candidates is a monumental task by itself. It is also a process where an analytic approach
to systems biology can provide significant breakthrough. In this dissertation, theoretical
frameworks towards effective treatment strategies in the context of probabilistic Boolean
networks, a class of gene regulatory networks, are addressed. These proposed analytical
tools provide insight into the design of effective therapeutic interventions.
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1CHAPTER I
INTRODUCTION
Cells form complex systems and can be approached by engineering methods. Their behav-
ior can be abstracted using many elements such as switches based on thresholds, memory,
feedback, and other elements common in engineering systems. Nevertheless, studying
cells can be challenging for an engineer. The primary problem is that cells are much more
complex than man-made systems in terms of the numbers of inputs involved in any given
decision. This situation is further exacerbated by the paucity of information that is avail-
able on the configuration of the regulatory networks and the dynamics of reconfiguration
of these same networks as a cell responds. Although high-throughput technologies such as
microarrays provide powerful tools to characterize genome or proteome, each only supplies
a snap-shot of the state of cells. With these technologies, we are beginning to characterize
information and its means of transmission within a biological system. Still, what we are still
lacking is how to use this knowledge to exert control over biological systems. Our prime
objective of our research is “Personalized Cancer Therapy” which is based on characteriz-
ing the treatment for every individual cancer patient. Knowing how one can systematically
alter the behavior of an abnormal cancerous cell will bring us closer to personalized cancer
therapy. Towards this objective, we are required to construct a model for the regulation of
the cell and utilize this model to devise effective treatment strategies. The proposed treat-
ments will have to be validated experimentally, but selecting good treatment candidates is
a monumental task by itself. It is also a process where an analytic approach to systems
biology can provide significant breakthrough.
This dissertation follows the style of IEEE Transactions on Biomedical Engineering.
2In this dissertation, we address theoretical frameworks towards effective treatment strate-
gies in the context of a given model of gene regulatory networks.
Most cellular processes involve many different molecules. The metabolism of a cell
consists of many interlinked reactions. Products of one reaction will influence the next,
thus forming the metabolic network [1]. Similarly, signaling molecules are interlinked and
cross-talk between the different signalling cascades forms the signaling network. The same
is true for regulatory relationships between genes and their products. All these networks
are closely related, e.g. the regulatory network is influenced by extracellular signals. Our
main interest is in transcription regulation networks and we will refer to them as “gene
regulatory networks”.
There have been numerous attempts to model the dynamical behavior of gene reg-
ulatory networks, ranging from deterministic to stochastic, using either discrete-time or
continuous-time descriptions of gene interactions. Paradigms that have been considered
in this context include Bayesian networks [2], Boolean networks [3], and, recently, proba-
bilistic Boolean networks [4].
A deterministic model of a gene regulatory network can involve a number of different
mechanisms that capture the collective behavior of the elements constituting the network.
What deterministic models have in common is that there is no inherent notion of random-
ness or stochasticity in the model once it is specified [4]. A model system that has received
much attention, not only from the biology community, but also in physics, is the Boolean
network model, originally introduced by Kauffman [3]. In this model, gene expression is
quantized to only two levels: ON and OFF. The expression level (state) of each gene is
functionally related to the expression states of some other genes, using logical rules [5].
In a Boolean network, each (target) gene is “predicted” by several other genes by means
of a Boolean function (predictor). Thus, after having inferred such a function from gene
expression data, it could be concluded that if we observe the values of the predictive genes,
3we know, with full certainty, the value of the target gene.
Conceptually, such an inherent determinism seems problematic as it assumes an en-
vironment with no uncertainty. However, the data used for the inference exhibits uncer-
tainty on several levels. First, there is biological uncertainty: gene expression is inherently
stochastic, not in the sense that it is totally random, but that it has a stochastic nature on
account of intrinsic biological variability. Second, there is experimental noise due to the
complex measurement process, ranging from hybridization conditions to microarray image
processing techniques. Third, there may be interacting latent variables, such as proteins,
various environmental conditions, or other genes that we simply do not measure, that fur-
ther add to the variability of the measurements. Thus, we are in a position of having to
infer a (deterministic) predictor under uncertainty. Probabilistic Boolean networks (PBNs)
have been introduced to address such uncertainty. A number of additional justifications for
introducing PBNs are contained in [5]. In this dissertation, we model the gene regulatory
network dynamics as a probabilistic Boolean networks.
PBNs allow the incorporation of uncertainty into the inter-gene relationships [6]. This
class of models offers a more flexible and powerful mathematical abstraction. PBN is
capable of incorporating the effect of latent variables, not directly captured in a Boolean
network. The dynamics of a PBN can be represented via a discrete-time Markov chain. A
logical state of the corresponding Markov chain is a gene activity profile.
Our ultimate objective in modeling genetic regulatory networks is the identification of
potential targets for therapeutic intervention [6]. For instance, in cancer, one can consider
correlation between metastasis and the abundances of mRNA for certain genes. In this re-
spect, the abundance of mRNA for the gene WNT5A has been found to be highly discrim-
inating between cells with properties typically associated with high versus low metastatic
competence [7]. Appropriate alteration in the expression of WNT5A can be perceived ther-
apeutically, and it can therefore be used to search for an optimal intervention strategy [8].
4In [9] and [4], several methods to design therapeutic interventions are discussed in the
context of probabilistic Boolean networks. Some of these methods are intended to reduce
the likelihood of the gene-expression profiles associated with aberrant cellular functions
via manipulation of a control gene. In a nutshell, whenever changing the expression level
of a control gene is perceived as a therapeutic option, these system-based therapies search
for the most effective sequence of such changes to beneficially alter cell dynamics. The
resulting intervention strategy specifies the appropriate expression of the control gene in
order to reduce the likelihood of pathological cellular functions.
Major efforts have initially focused on manipulating external (control) variables to
desirably affect dynamical evolution over a finite time horizon [10]. These short-term poli-
cies have been shown to change the dynamical performance of regulatory networks over a
small number of stages; however, they are not necessarily effective in changing long-run
network behavior. To address this issue, stochastic control has been employed via dynamic
programming algorithms to find stationary control policies that affect the steady-state dis-
tributions of PBNs [11].
In this dissertation, we first address one practical issue in the inference of PBNs from
biological data [4]. A significant effort has been put forth to infer PBNs. The inference
problem depends on the kinds of data available. Data are often assumed to come from the
steady-state distribution of the underlying biological network. This is typically the case for
cancer patient data. We show how and why using the coefficient of determination (CoD) in
the inference of PBNs can lead to artifacts in the structure of the network. We also propose
an inference algorithm to avoid such artifacts.
Formulating the problem of intervention in a regulatory network as a classical infinite-
horizon decision making process introduces an elegant analytical framework that may be
instrumental to enhance our understanding of treatment discovery. Despite its conceptual
benefits, the classical intervention fails to address many practical and technical issues. In
5the past few years, the classical framework has been extended in several directions to im-
prove system-based intervention schemes. To this end, we consider three control theoretic
problems in the context of PBNs. These proposed analytical tools provide insight into
the design of effective therapeutic interventions. These methods strive to address some of
the practical concerns that are brought up by medical practitioners. In the following, we
explain them in more details.
A. Boolean Networks and Bidirectional Gene Relationships
The coefficient of determination (CoD) has been used to infer Boolean networks from
steady-state biological data, in particular, to estimate the constituent Boolean networks for
a probabilistic Boolean network. The advantage of the CoD method over design methods
that emphasize graph topology or attractor structure is that the CoD produces a network
based on strong predictive relationships between target genes and their predictor (parent)
genes. The disadvantage is that spurious attractor cycles appear in the inferred network, so
that there is poor inference relative to the attractor structure, that is, relative to the steady-
state behavior of the network. An attractor is a set of states to which a Boolean network
evolves after a long enough time. Given steady-state data, there should not be a significant
amount of steady-state probability mass in the inferred network lying outside the mass of
the data distribution; however, the existence of spurious attractor cycles creates a significant
amount of steady-state probability mass not accounted for by the data.
Using steady-state data hampers design because the absence of temporal data causes
the CoD method to suffer from a lack of directionality with regard to prediction. This may
result in spurious bidirectional relationships among genes in which two genes are among
the predictors for each other, when actually only one of them should be a predictor of the
other, thereby creating a spurious attractor cycle. Chapter III characterizes the manner in
6which bidirectional relationships affect the attractor structure of a Boolean network. Given
this characterization, we propose a constrained CoD inference algorithm that outperforms
unconstrained CoD inference in avoiding the creation of spurious non-singleton attractor.
Algorithm performances are compared using a melanoma-based probabilistic Boolean net-
work [12].
B. Timing in Probabilistic Boolean Networks
Implementation of an intervention policy derived for probabilistic Boolean networks re-
quires nearly continuous observation of the underlying biological system since precise ap-
plication requires the observation of all transitions. In medical applications, as in many
engineering problems, the process is sampled at discrete time intervals and a decision to
intervene or not must be made at each sample point.
In this work, we construct a framework for gene interactions such that the model
class: (i) incorporates rule-based dependencies among genes, (ii) allows the systematic
study of global network dynamics, (iii) is able to cope with uncertainty, (iv) accounts for
the sampling rate of temporal profiles, (v) remains robust to large estimation errors due to
small samples. To this end, in Chapter IV, we extend the current definition of PBN and
propose a discrete-time discrete-space model called sampling-rate-dependent PBN (SRD-
PBN) [13].
C. Optimal Cyclic Control Policy
We are able to exploit the biochemical differences between bacteria and human cells so as
to achieve toxic drug concentrations in the former while sparing the latter. This selectiv-
ity largely contributes to the success in treating bacterial infections. Unfortunately, such
high selectivity is at present elusive in the treatment of human cancers. Hence, great ef-
7forts are required to determine dose schedules that maximize the benefit-to-toxicity ratio
in cancer therapy [14]. Dose intensity is a measure of treatment delivery that looks at the
amount of drug delivered per unit of time. To mitigate the detrimental side effects of a
treatment in general, we should account for dose intensity in a system-based intervention
method. Therapeutic intervention should avoid undesirable gene-expression profiles while
accounting for the quantity or frequency of applied drugs. A higher drug dose intensity can
be delivered by increasing the dose per cycle (dose escalation) or by reducing the interval
between cycles (dose density).
To reduce the side-effects, certain types of cancer therapies, such as chemotherapy,
are given in cycles with each treatment being followed by a recovery period. During the
recovery period, the side effects tend to gradually subside. In Chapter V, we show how
an optimal cyclic intervention strategy can be devised for a PBN. The effectiveness of
optimal cyclic therapies is demonstrated through numerical studies for random networks.
Furthermore, an optimal cyclic policy is derived to control the behavior of a regulatory
model of the mammalian cell-cycle network [15].
D. Mean-First-Passage-Time Control Policy
In general, dynamical programming algorithms can be problematic owing to their high
computational complexity. Two additional computationally burdensome issues that arise in
cancer therapy are the potential for controlling the network and identifying the best gene
for intervention. Chapter VI proposes an algorithm based on mean first-passage time that
assigns a stationary control policy for each gene candidate. It serves as an approximation
to an optimal control policy and, because of its reduced computational complexity, can be
used to predict the best control gene. Once the best control gene is identified, one can
derive an optimal policy or simply utilize the approximate policy for this gene when the
8network size precludes a direct application of dynamic programming algorithms. A salient
point is that the proposed algorithm can be model-free. It can be directly designed from
time-course data without having to infer the transition probability matrix of the network
[16].
To set the stage, in Chapter II, we first introduce the background of this research in
more details. Chapter III considers the bidirectional relationships in Boolean networks. In
Chapter IV, we introduce how sampling-rate can be incorporated in probabilistic Boolean
networks. We develop a novel framework to model cyclic cancer treatments such as chemother-
apy in Chapter V. We propose a heuristic control design method based on mean-first-
passage-times in Markov chains in Chapter VI.
9CHAPTER II
BACKGROUND
A. Boolean Networks
A Boolean network (BN) G(V, F ), [17], is defined by a sequence V = {xi}ni=1 of n nodes
and a set of Boolean functions f = {f 1, ..., fn}where xi ∈ {0, · · · , d − 1} and d denotes
the quantization level. In gene regulatory modeling, xi represents the expression level of
gene i, which can be either active (1) or inactive (0). As is commonly done, we will mix
terminology by referring to the nodes as genes. The set of Boolean functions f represents
the regulatory rules between genes. At time step t+1, the expression of gene xi, called the
target gene, is predicted by the expression of a set, W i, of genes at time step t, based on the
regulatory function fi. The sequence of genes W i = {xi1 , ..., xiki} is called the predictor
set of xi. The function f i is called the predictor function of xi. We assume that there are no
nonessential genes in a predictor set, meaning that the predictor function requires the full
set as input. The cardinality of Wi, |Wi|, is called the connectivity of xi and the maximum
connectivity in the network is called the connectivity of the network.
A state of the BN at time t is a vector (x1(t), ..., xn(t)) of gene values which also
referred to as gene activity profile. The possible states of the BN form its state space.
Given an initial state, the network will eventually enter a set of states through which it will
repeatedly cycle forever. Each such set is called an attractor cycle, and a singleton attractor
is an attractor cycle of length 1. The attractor cycles are mutually disjoint. The set of all
states that transition into an attractor cycle is called the basin of that cycle. The family of
basins partitions the state space.
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B. Probabilistic Boolean Networks
Probabilistic Boolean network (PBN) [6] consists of a sequence V = {xi}ni=1 of n nodes
with xi ∈ {0, · · · , d − 1}, together with a sequence {fc}kc=1 of vector-valued network
functions. In the framework of gene regulation, each element xi represents the expression
level of a gene. It is common to mix the terminology by referring to xi as the ith gene. The
state vector x(t) = (x1(t), . . . , xn(t)) is called the gene-activity profile (GAP) at time t.
Each network function fc = (fc1, . . . , fcn) determines a constituent network (context) of the
regulatory network. The function fci : {0, . . . , d−1}n → {0, . . . , d−1} is the predictor of
gene i, whenever network c is selected. At each updating epoch a decision is made whether
to switch the constituent network. This decision is based on a binary random variable ξ
with P (ξ = 1) = q. If ξ = 0, then the network is not switched, the model behaves like
a fixed network and the values of all genes are synchronously updated according to the
current constituent network. If ξ = 1, then a constituent network is randomly selected
from among all constituent networks, including the current one, according to the selection
probability distribution {pc}kc=1 and, after selecting fc, the values of all genes are updated
accordingly. If q = 1, so that a switch is permitted at every time point, the network is said
to be instantaneously random; if q < 1, then the PBN will remain in a constituent network
so long as ξ remains equal to 0, and the PBN is said to be context-sensitive.
Two quantization levels have thus far been used in practice. If d = 2 (binary), then
the constituent networks are Boolean networks with 0 or 1 meaning OFF or ON, respec-
tively. The case d = 3 (ternary) arises when we consider a gene to be 0 (down-regulated),
2 (up-regulated), and 1 (invariant). This latter situation commonly occurs with cDNA mi-
croarrays, where a ratio is taken between the expression values on the test channel (red)
and the base channel (green). In this work, we will develop the methodology for d = 2,
so that gene values are either 0 or 1; however, the methodology is applicable to any finite
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number of levels. For binary PBNs, there is a natural bijection between the GAP x(t) and
its integer representation, x(t), which takes values inW = {0, 1, . . . , 2n−1}. We consider a
PBN with perturbation, meaning that there is a binary random vector γ = (γ1, γ2, . . . , γn),
independent of ξ, such that P (γi = 1) = p, and γ1, γ2, . . . , γn are independent. If γ = 0
the network transitions according to the network function, and if γ 6= 0 the value xi flips if
and and only if γi = 1.
The dynamic behavior of an instantaneous PBN can be modeled by a Markov chain
with state space of W . Similarly, the dynamic behavior of a context-sensitive PBN can be
modeled by a Markov chain whose states consist of (context, GAP) ordered pairs taking
values in
{
(c, x) : c ∈ {1, . . . , k} , x ∈ W
}
.
In either frameworks, let P denote the transition probability matrix of the correspond-
ing Markov chain where the state space is denoted as S. The evolution of the network can
be modeled by a stationary discrete-time equation
z(t+ 1) = f(z(t), w(t)) for t = 0, 1, . . .,
where state z(t) ∈ S. The disturbance w(t) is the manifestation of uncertainties, due to
either network switching or a change in gene-activity profile resulting from a random gene
perturbation. Gene perturbation insures that all states in the Markov chain communicate
with one another. Hence, the finite-state Markov chain is ergodic and has a unique steady-
state distribution.
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C. Optimal Control in Probabilistic Boolean Networks
In the following, we describe how to devise an optimal control policy for a PBN. Let
P = (pij; i, j ∈ S) denote the transition probability matrix of the Markov chain corre-
sponding to the context-sensitive or instantaneous PBN. In the presence of external con-
trol, we suppose that there exists a binary control input, u(t) ∈ C = {0, 1}. A control
u(t), which can take values 0 or 1 at each updating epoch t, specifies the action on the
control gene. Treatment alters the status of the control gene, which can be selected among
all genes in the network. If the control at updating epoch t is on, u(t) = 1, then the state
of the control gene is toggled; if u(t) = 0, then the state of the control gene remains
unchanged. In the presence of external control, the system evolution is represented by a
stationary discrete-time equation
z(t+ 1) = f(z(t), u(t), w(t)) for t = 0, 1, . . .
where state z(t) is an element of the state-space S; and w(t) is the manifestation of uncer-
tainties in the model. The probability of transitioning from state i to state j under control
u is denoted by pij(u), where i, j ∈ S.
The problem of optimal intervention for a PBN is formulated as an optimal stochastic
control problem. A cost-per-stage, g(i, u, j), is associated to each intervention in the sys-
tem. In general, a cost-per-stage may depend on the origin state i, the successor state j, and
the control input u. We assume that the cost-per-stage is stationary and bounded for all i, j
in S, and u in C = {0, 1}. We define the expected immediate cost in state i, when control
u is selected, by
g(i, u) =
∑
j∈S
pij(u) g(i, u, j).
We consider the discounted formulation of the expected total cost. The discounting
factor, α ∈ (0, 1), ensures convergence of the expected total cost over the long-run [18].
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In the case of cancer therapy, the discounting factor emphasizes that obtaining treatment
at an earlier stage is favored over later stages. The expected total discounted cost, given a
policy pi and an initial state i, is denoted by
Jpi(i) = lim
N→∞
E
{
N−1∑
t=0
αt r(z(t), µt(z(t)), z(t + 1))
∣∣∣∣z(0) = i
}
, (2.1)
where z(t), i ∈ S. A policy pi = {µ0, µ1, . . .} is a sequence of decision rules µt : S → C,
for each time step t. The vector Jpi of the expected total costs is called the value function. In
a stochastic control problem, we seek an intervention strategy pi∗ among all the admissible
intervention strategies Π that minimizes the value function for each state i, i.e.,
pi∗(i) = arg min
pi∈ Πg
Jpi(i), ∀ i ∈ S. (2.2)
For a finite time horizon, the dynamic programming algorithm describes how the op-
timal cost Jk+1 propagates backward in time to the optimal cost Jk
Jk(i) = min
u∈C
[
g(i, u) + λ
N−1∑
j=0
pi,j(u)Jk+1(j)
]
. (2.3)
The above equation motivates the introduction of the mapping T : S 7→ ℜ defined by
TJ(i) = min
u∈C
[
g(i, u) + λ
N−1∑
j=0
pi,j(u)J(j)
]
, ∀i ∈ S, (2.4)
for any value function J : S 7→ ℜ. Given the mapping of (2.4), the following propositions
summarize how one can devise an optimal one-transition policy. Proofs of these statements
can be found in [18].
Proposition 1 (Convergence of the discounted cost algorithm): For any x ∈ S and any
bounded function J : S 7→ ℜ, the optimal cost function satisfies
J∗(x) = lim
M−→∞
(
TMJ
)
(x), ∀x ∈ S.
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Proposition 2 (Bellman’s optimality equation): The optimal cost function J∗ satisfies
J∗ = TJ∗. (2.5)
Furthermore, J∗ is the unique solution of this equation within the class of bounded func-
tions.
Proposition 3 (Necessary and sufficient condition for optimality): A stationary policy µ is
optimal if and only if it attains the minimum in Bellman’s optimality equation of (2.5).
The three aforementioned propositions provide the basis for a method for determining
an optimal one-transition policy. Proposition 2 asserts that the optimal cost function satis-
fies Bellman’s optimality equation while Proposition 1 states that the optimal cost function
can be iteratively determined by running the recursion equation
Jk+1 = TJk, k = 0, 1, 2, . . . (2.6)
for any bounded initial cost function J0 : S 7→ ℜ. Since this iteration is guaranteed to
converge to J∗, one can continue the iteration until some stopping criterion is reached.
By Proposition 3, the resulting optimal policy is also stationary. The procedure described
in (2.6) is referred to as the value iteration algorithm since, at every stage, we are iterating
on the value function. The optimal one-transition policy is obtained as the argument of the
minimization step once the iterative procedure has converged.
D. Continuous-time Markov Chain
Consider a continuous-time discrete-space stochastic process {Z(t), t ≥ 0} taking on val-
ues in the set of nonnegative integers S. In analogy with a discrete-time Markov chain,
we say that the process {Z(t), t ≥ 0} is a continuous-time Markov chain if ∀s, t ≥ 0, and
nonnegative integers i, j, z(ν) ∈ S, 0 ≤ ν < s,
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Pr{Z(t+ s) = j|Z(s) = i, Z(ν) = z(ν), 0 ≤ ν < s} =
Pr{Z(t+ s) = j|Z(s) = i}.
In other words, a continuous-time Markov chain is a stochastic process with the Markovian
property. This means that the conditional distribution of the future state at time t+ s, given
the present state at time s and all the preceding states, depends only on the present state
and is conditionally independent of the states prior to the current state. The past given the
present does not provide more information about the future.
If we let τi denote the amount of time that the process stays in state i before making a
transition into a different state, then the Markov property implies
Pr{τi > s + t|τi > s} = Pr{τi > t}, ∀ s, t ≥ 0.
The random variable τi is memoryless and must therefore be exponentially distributed. In
general, a continuous-time Markov chain is defined by a Q-matrix. A Q-matrix on S is a
matrix Q = (qij; i, j ∈ S) satisfying the following conditions [19]:
(i) 0 ≤ −qii <∞, ∀i;
(ii) qij ≥ 0, ∀ i 6= j;
(iii)
∑
j∈I qij = 0, ∀i.
(2.7)
In the above, qij is the rate of transitioning from i to j and qi =
∑
i6=j qij is the rate of
leaving state i. It is known that a matrix Q is a Q-matrix on S if and only if P(t) = eQt is
a stochastic matrix, ∀t ≥ 0 [19]. In particular, the transition probability from i to j after t
unit of time, the (i, j) element of P(t), is given by
Pr(Xt = j|X0 = i) = p
t
ij =
[
eQt
]
ij
.
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E. Influence in Probabilistic Boolean Networks
Influence is a method for quantifying the relative impact of genes on other genes within the
context of PBNs [5]. The influence Ij(f) of gene xj on the function f , with respect to the
probability distribution D(x), x ∈ {0, 1}n, is defined as
Ij(f) = ED
[
∂f(x)
∂xj
]
, (2.8)
whereED[·] is the expectation operator with respect to the distributionD, ∂f(x)∂xj = f(x
(j,0))⊕
f(x(j,1)) is the partial derivative of the Boolean function f , the symbol⊕ is addition modulo
2 (exclusive OR), and x(j,k) = (x1, ..., xj−1, k, xj+1, ..., xn) for k ∈ {0, 1}. In other words,
(2.8) gives the influence as the probability (under the distribution D(x)) that a toggle of
the jth variable changes the value of the function. In the context of PBNs, the influence
of gene xk on gene xi is given by Ik(xi) =
∑l(i)
j=1 Ik(f
(i)
j ) · p
(i)
j where {p
(i)
j }
l(i)
j=1 are the
selection probabilities of the predictor functions of gene i and l(i) represents the number of
predictor functions of gene i [5]. To quantify the long-run influence, D(x) is the stationary
distribution of the PBN.
F. Biological Data
In the theoretical frameworks we developed, we consider two gene regulatory networks that
have been derived from biological data. In the following, these two networks are introduced
in more details.
1. Melanoma Gene Regulatory Network
The steady-state data was collected in a profiling study of metastatic melanoma in which
the abundance of messenger RNA for the gene WNT5A was found to be highly discrimi-
nating between cells with properties typically associated with high metastatic competence
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versus those with low metastatic competence [7]. These findings were validated and ex-
panded in a second study, in which experimentally increasing the levels of the WNT5A
protein secreted by a melanoma cell line via genetic engineering methods directly altered
the metastatic competence of that cell as measured by the standard in vitro assays for metas-
tasis [20]. A further finding of interest in this study was that an intervention that blocked the
WNT5A protein from activating its receptor, the use of an antibody that binds the WNT5A
protein, can substantially reduce WNT5A’s ability to induce a metastatic phenotype. This
suggests control based on intervention that alters the contribution of the WNT5A gene to
biological regulation. Disruption of this influence can potentially reduce the chance of a
melanoma metastasizing, a desirable outcome. Ten genes, including the WNT5A gene,
were selected in [21] based on the predictive relationships among 587 genes: WNT5A,
pirin, S100P, RET1, MMP3, PHOC, MART1, HADHB, Synuclein, and STC3. We apply
the design procedure proposed in [22] to generate a PBN possessing four constituent BNs.
The method of [22] generates BNs with given attractor structures and the overall PBN is
designed so that the data points, which are assumed to come from the steady-state dis-
tribution of the network, are attractors in the designed PBN. This approach is reasonable
because our interest is in controlling the long-run behavior of the network. The control
objective for this 10-gene network is to down-regulate the WNT5A gene, because WNT5A
ceasing to be down-regulated is strongly predictive of the onset of metastasis. A number
of other control studies based on the same data have aimed to down-regulate the WNT5A
gene. This model has been used because the relation of WNT5A to metastasis is well es-
tablished and the binary nature of the up or down regulation suits a binary model. A state
is desirable if WNT5A = 0 and undesirable if WNT5A = 1. In this example, the use of
the state WNT5A has resulted from biological knowledge relating the state of WNT5A to
metastasis in melanoma tumors.
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2. Mammalian Cell-Cycle Network
In this section, we construct a PBN that is a probabilistic version of the Boolean model for
the mammalian cell cycle regulation proposed in [23]. This PBN postulates the mammalian
cell cycle with a mutated phenotype.
During the late 1970s and early 1980s, yeast geneticists identified the cell-cycle genes
encoding for new classes of molecules, including the cyclins (so-called because of their
cyclic pattern of activation) and their cyclin dependent kinases (cdk) partners [23]. Our
model is rooted in the work of Faure et al., who have recently derived and analyzed the
Boolean functions of the mammalian cell cycle [23]. The authors have been able to quan-
titatively reproduce the main known features of the wild-type biological system, as well as
the consequences of several types of mutations.
Mammalian cell division is tightly controlled. In a growing mammal, the cell division
should coordinate with the overall growth of the organism. This coordination is controlled
via extra-cellular signals. These signals indicate whether a cell should divide or remain in
a resting state. The positive signals, or growth factors, instigate the activation of Cyclin D
(CycD) in the cell.
The key genes in this model are CycD, retinoblastoma (Rb), and p27. Rb is a tumor-
suppressor gene. This gene is expressed in the absence of the cyclins, which inhibits the Rb
by phosphorylation. Whenever p27 is present, Rb can be expressed even in the presence of
CycE or CycA. Gene p27 is active in the absence of the cyclins. Whenever p27 is present,
it blocks the action of CycE or CycA. Hence, it stops the cell cycle. Table I summarizes
the Boolean functions of the wild-type cell cycle network.
The preceding explanation represents the wild-type cell-cycle model. Following one
of the proposed mutations in [23], we assume p27 is mutated and its logical rule is always
zero (OFF). In this cancerous scenario, p27 can never be activated. As we mentioned
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earlier, whenever p27 is present, Rb can be expressed even in the presence of CycE or
CycA. For the mutated cell cycle network, p27 is always zero and Rb cannot be expressed
in a case where CycD is not present but CycE or CycA are active [23]. This mutation
introduces a situation where both CycD and Rb might be inactive. As a result, in this
mutated phenotype, the cell cycles in the absence of any growth factor. In other words, we
consider the logical states in which both Rb and CycD are down-regulated as ‘undesirable
states’, when p27 is mutated. Table II summarizes the mutated Boolean functions.
The Boolean functions in Table II are used to construct the PBN model for the cell
cycle. To this end, we assume that the extra-cellular signal to the cell-cycle model is a
latent variable. The growth factor is not part of the cell and its value is determined by the
surrounding cells. The expression of CycD changes independently of the cell’s content
and reflects the state of the growth factor. Depending on the expression status of CycD,
we obtain two constituent Boolean networks for the PBN. The first constituent Boolean
network is determined from Table II when the value of CycD is equal to zero. Similarly,
the second constituent Boolean network is determined by setting the variable of CycD to
one. Here, we set the perturbation probabilities equal to 10−3.
According to Table II, the cell-cycle PBN consists of nine genes: CycD, Rb, E2F,
CycE, CycA, Cdc20, Cdh1, UbcH10, and CycB. The above order of genes is used in the
binary representation of the logical states, with CycD as the most significant bit and CycB
as the least significant bit. This order of genes in the logical states facilitates the presenta-
tion of our results and does not affect the computed control policies.
Having CycD and Rb as the most significant genes, we assume that the down regula-
tions of the CycD and Rb, i.e. the cell growth in the absence of growth factors, is unde-
sirable. Consequently, the state-space is partitioned into undesirable states and desirable
states. Application of methods developed for control of gene regulatory networks requires
the designation of desirable and undesirable states, and this depends upon the existence of
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Table I. Boolean functions of normal mammalian cell cycle.
Product Predictors
CycD Input
Rb (CycD ∧ CycE ∧ CycA ∧ CycB) ∨ (p27 ∧ CycD ∧ CycB)
E2F (Rb ∧ CycA ∧ CycB) ∨ (p27 ∧Rb ∧ CycB)
CycE (E2F ∧ Rb)
CycA (E2F ∧ Rb ∧ Cdc20 ∧ (Cdh1 ∧ UbcH10)) ∨ (CycA ∧Rb ∧ Cdc20 ∧ (Cdh1 ∧ UbcH10))
p27 (CycD ∧ CycE ∧ CycA ∧ CycB) ∨ (p27 ∧ (CycE ∧ CycA) ∧ CycB ∧ CycD)
Cdc20 CycB
Cdh1 (CycA ∧ CycB) ∨ (Cdc20)
UbcH10 (Cdh1) ∨ (Cdh1 ∧ UbcH10 ∧ (Cdc20 ∨ CycA ∨ CycB))
CycB (Cdc20 ∧ Cdh1)
relevant biological knowledge. In the cell-cycle example when p27 is mutated, we consider
the logical states in which both Rb and CycD are down-regulated as undesirable states. We
assume that the cost of the logical states with down-regulated Rb and CycD is higher than
that for the states in which these two genes are not simultaneously down-regulated.
Table II. Mutated Boolean functions of mammalian cell cycle.
Product Predictors
CycD Input
Rb (CycD ∧ CycE ∧ CycA ∧ CycB)
E2F (Rb ∧ CycA ∧ CycB)
CycE (E2F ∧Rb)
CycA (E2F ∧Rb ∧ Cdc20 ∧ (Cdh1 ∧ UbcH10)) ∨ (CycA ∧ Rb ∧ Cdc20 ∧ (Cdh1 ∧ UbcH10))
Cdc20 CycB
Cdh1 (CycA ∧ CycB) ∨ (Cdc20)
UbcH10 (Cdh1) ∨ (Cdh1 ∧ UbcH10 ∧ (Cdc20 ∨ CycA ∨ CycB))
CycB (Cdc20 ∧ Cdh1)
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CHAPTER III
BOOLEAN NETWORKS AND BIDIRECTIONAL GENE RELATIONSHIPS∗
Various models have been proposed for gene regulatory networks [24] and great efforts
have been made on the inference of these networks from gene expression data. Perhaps the
key issue concerning network inference is the large space of networks from which a model
must be selected in relation to the amount of data typically available. This dimension-
ality problem drives inference in two directions: (1) towards coarse-grained models that
require less data for inference [25], and (2) application of biological constraints [26]. This
Chapter concerns the inference of Boolean networks. For these networks, several inference
methods have been proposed [27, 28, 5, 29]. These methods generally assume time-course
data; however, here we are concerned with inference from time-independent data, the kind
of data one typically obtains from microarray studies involving human subjects. In this
context, it is generally assumed that the data come from the steady state of the network.
The long-run behavior of a Boolean network is characterized by its attractor cycles.
The attractor cycles in Boolean networks modeling biological systems are typically as-
sociated with phenotypes and tend to be short [17, 30, 3], with biological state stability
contributing to singleton attractors [31]. Singleton attractors have been associated with
phenotypes such as cell proliferation and apoptosis [32]. For this reason, in the absence of
time-course data to indicate the contrary, it is sometimes assumed that the data states rep-
resent singleton attractors. This assumption is enhanced when a Hamming-distance filter is
applied to the data states to act as a noise filter, because the filter results in a small number
of data states, each differing significantly among the components of the states [33].
∗ Reprinted with permission from “Inference of Boolean Networks under Constraint
on Bidirectional Gene Relationships” by G. Vahedi, I. Ivanov, E. R. Dougherty, 2009, IET
Systems Biology, 3, 191-202, Copyright 2009 by IET Systems Biology.
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One method proposed for inference from steady-state data involves the coefficient
of determination (CoD) [34]. Given a set of predictor variables and a target variable to
be predicted, the CoD measures the relative decrease in prediction error when using the
predictor variables in comparison to using the best estimate of the target in the absence
of knowledge concerning other variables. The CoD was the first method used to infer
probabilistic Boolean networks (PBNs) [5].
A fundamental issue is that, without time-course data, the CoD cannot provide infor-
mation on the direction of prediction. This problem manifests itself in the situation where,
if gene a is a high CoD predictor of gene b, then gene b is typically a high CoD predictor
of gene a. We refer to this situation as a bidirectional relationship between genes a and
b. The presence of bidirectional relationships affects the attractor structure of a Boolean
network, and this impacts the inference process with the result being that the inferred net-
work possesses spurious attractor cycles. The problem is sufficiently troublesome that it
has suppressed the use of CoD inference methods. The inference methods that have taken
its place are primarily based on the attractor structure, with either secondary or no concern
for the predictive relations between individual genes in the network [22, 33]. This kind of
approach is natural when attractor structure is of primary interest.
In this chapter, we will accomplish both goals in network design: preservation of at-
tractor structure and connectivity based on strong gene prediction. To accomplish this aim,
we investigate the bidirectional effects for Boolean networks with connectivity K = 1
or K = 2, the connectivity of a Boolean network being the maximum number of vari-
ables allowed for a Boolean function. As a consequence of our analysis, we propose a
novel constrained CoD-based inference algorithm that performs significantly better than
unconstrained CoD inference relative to the attractor structure. We note that the number of
attractor cycles and their average lengths in random Boolean networks has recently been
addressed for the case of connectivityK = 1, and it is clear that even this seemingly simple
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structure presents challenge for both analytical and computational approaches [35].
We will begin by defining the bidirectional relationship among two genes of a net-
work. We then investigate the effect of such relationships on the attractor structure on
specific classes of Boolean networks. After discovering how the bidirectional relation-
ships influence the attractor structure of a Boolean network, and providing estimates of
encountering such relationships and particular attractor structures, we discuss CoD-based
inference. We then propose a novel algorithm that mitigates bidirectional relationships and
we provide simulation results that support our analysis. Lastly, we present an application
of the proposed algorithm to melanoma gene expression data and compare its performance
to unconstrained CoD inference procedures.
A. Bidirectional Relationships
Our particular interest is with how genes that are predictors of each other affect the attractor
structure. As noted in the Introduction of this Chapter, when such pairs arise on account
of network inference, they can lead to the existence of certain attractor structures. This
motivates the following definition.
Definition 1 The genes xi and xj in a BN are said to have a bidirectional relationship iff
xi ∈Wj and xj ∈Wi. The relationship is said to be of connectivity n if |Wi| = |Wj| = n.
To say that xi and xj have a bidirectional relationship of connectivity n is to say that
they have a bidirectional relationship and each has connectivity n. Alternatively, one might
have defined the relationship to be of connectivity n if max{|Wi|, |Wj|} = n, or to be of
connectivity (m,n) if |Wi| = m and |Wj | = n, the rationale behind the first alternative
being to bound the complexity of the predictor relations and the second being to specify
directly the predictor-set cardinalities. We have defined order n as we have because it
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characterizes the most complex case when one of the predictor sets has cardinality n. It is
this maximum complexity that interests us.
We will investigate the effect of bidirectionality on the attractor structure, provide es-
timates of how often such bidirectional relationships happen, and derive a lower bound es-
timate for the probability of a BN with such relationships having at least one non-singleton
attractor cycle. We first consider connectivity 1 and show that there is at least one non-
singleton attractor cycle in the BN. Next we consider connectivity 2. There we will see
that even such a minimal increase of the cardinality of the predictor sets complicates the
analysis of the attractor structure.
1. Connectivity-1 Didirectionality
Proposition 4 If there are two genes in a BN having a bidirectional relationship of con-
nectivity 1, then the BN has at least one non-singleton attractor cycle.
Proof
Without loss of generality assume the two genes are x1 and x2. There are four possible
transition pairs of predictor functions for these genes: (1) f1 ≡ x2 and f2 ≡ x1; (2) f1 ≡ x2
and f2 ≡ x1; (3) f1 ≡ x2 and f2 ≡ x1; and (4) f1 ≡ x2 and f2 ≡ x1, where the overbar
denotes negation.
Consider the first possible pair: f1 ≡ x2 and f2 ≡ x1. If the transitions start from
the point 01y, then after finitely many transitions, the BN will enter an attractor 01x0 or
10y0, where y, y0 and x0 denote vectors of the remaining gene values. Assume that the first
visited attractor state is 01x0 (the other possibility 10y0 can be considered in the same way).
Because x1 and x2 depend only on each other and 01x0 is an attractor state, from this point
on the network must follow a transition sequence of the form 01x0,10x1,01x2,..., 01xk,
where xk = x0 and xr 6= x0 for 1 ≤ r < k. Thus, the sequence forms an attractor cycle
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of length k = 2m > 1. It is straightforward to show that similar cycles are formed when
f1 ≡ x2 and f2 ≡ x1.
Next, we consider the predictor functions pair: f1 ≡ x2 and f2 ≡ x1. If the transitions
start from any point of the form x1x2y, then after finitely many transitions the BN will enter
an attractor state that is of one of the following forms: 00x0, 01y0, 10z0 or 11u0. Here
we consider the case when the first visited attractor state is 00x0 (the other possibilities
can be considered similarly). Because x1 and x2 depend only on each other and 00x0 is
an attractor state, from this point on the network must follow a transition sequence of the
form, 00x0,01x1,11x2,10x3, . . . , 00xk, where xk= x0 and xr 6= x0 for 1 ≤ r < k. Thus,
the sequence forms an attractor cycle of length k = 4m > 1. It is straightforward to show
that similar cycles are formed when f1 ≡ x2 and f2 ≡ x1. 
2. Connectivity-2 Bidirectionality
Suppose x1 and x2 have a bidirectional relationship of order 2 with W1 = {x2, x4} and
W2 = {x1, x3}. Because all predictor variables are essential, the following conditions
cannot occur (refer to the truth tables for f1 and f2):
1. (a1 = c1 and b1 = d1) or (a2 = c2 and b2 = d2)
2. (a1 = b1 and c1 = d1) or (a2 = b2 and c2 = d2)
Table III. Truth tables for f1 and f2.
x2 x3 f1
0 0 a1
0 1 b1
1 0 c1
1 1 d1
x1 x4 f2
0 0 a2
0 1 b2
1 0 c2
1 1 d2
Moreover, any combination of f1 and f2 belongs to at least one of the following (not
mutually exclusive) classes:
26
F1: a1 = c1 and a2 = c2
F2: a1 = c1 and b2 = d2
F3: b1 = d1 and a2 = c2
F4: b1 = d1 and b2 = d2
Proposition 5 If a BN possesses a pair of genes that have a bidirectional relastionship of
connectivity 2, then at least 1
8
of the states in its state space cannot be singleton attractors
of the network.
Proof
Without loss of generality, suppose x1 and x2 have a bidirectional relationship of order
2 with W1 = {x2, x4} and W2 = {x1, x3}. To prove the proposition, we consider the
following four cases: (a) (f1, f2) ∈ F1 and x3x4 = 00; (b) (f1, f2) ∈ F2 and x3x4 = 01;
(c) (f1, f2) ∈ F3 and x3x4 = 10; and (d) (f1, f2) ∈ F4 and the states of the BN were
x3x4 = 11.
For case (a), first consider (f1, f2) ∈ F1 such that a1 = c1 = 0 and a2 = c2 = 0.
Examination of the truth tables of f1 and f2, Table III, where a1 = c1 = 0 and a2 = c2 = 0,
together with the assumed constant values of x3 and x4, shows that any state with x3x4 = 00
and x1 = x2 cannot be a singleton attractor. A simple counting argument shows that the
states where x3x4 = 00 and x1 = x2 account for exactly 1/8 of all of the states in state
space. Reasoning in the same way, one can check that when (f1, f2) ∈ F1 with a1 = c1 = 1
and a2 = c2 = 1, the states with x3x4 = 00 and x1 = x2 cannot be singleton attractors,
and that there are exactly 1/8 such states in the state space. To complete the analysis of
case (a), consider the situation where (f1, f2) ∈ F1 with a1 = c1, a2 = c2, and a1 = a2. In
this case, examination of the the truth tables of f1 and f2 shows that all of the states where
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x3x4 = 00 cannot be singleton attractors. It is straightforward to count that exactly 1/4 of
the states in the state space are of this type.
Using similar arguments and symmetry considerations, one can show that the propo-
sition holds for cases (b), (c) and (d). 
B. Algorithm
1. CoD-based Inference of BNs
The coefficient of determination (CoD) is a general non-linear statistical method to select a
set of predictors for a given gene. It measures the degree to which the transcriptional levels
of an observed (predictor) gene set can be used to improve the prediction of the transcrip-
tional level of a target gene relative to the best prediction in the absence of observations. If
xi, Wi, and fi are the target gene, the predictor set, and the predictor function for the target
gene, respectively, then the CoD for the target gene xi is given by
θi =
ε0 − ε(xi, fi(Wi))
ε0
where ε0 is the error of the best estimate of xi in the absence of any conditional variables
and ε(xi, fi(Wi)) is the prediction error of the target gene according to the observations of
the predictor set Wi [34]. For minimum mean-square error estimation, ε0 is the error of the
prediction of xi with its mean.
The previous propositions explain why very often the CoD-inferred BNs possess spu-
rious non-singleton attractors. We propose an algorithm to correct this undesirable behav-
ior. We make the typical assumption that the data come from the steady state, and we apply
the constraint that each data point is a singleton attractor.
Since the predictor function of each target gene is estimated from the steady-state data,
not time-series data, each gene is a perfect estimator of itself (CoD equal to 1). To eliminate
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this trivial case, no gene can be a member of its own predictor set. Therefore, for n genes,
for each target gene, there are
∑ki
m=1C
n−1
m possible combinations for Wi, where ki is the
maximum cardinality of Wi.
We employ a method called full-logic to estimate the predictor function and conse-
quently the CoD for all possible combinations of predictor sets of each target gene. The
CoD estimates a predictor function from the highest occurrence frequency of the target
gene based on the values of all of the possible sets of predictor genes in the data set. More
details regarding the full-logic method can be found in [36]. Note that there may be more
than one high CoD predictor set for a target gene.
2. Singleton Attractor CoD Inference Algorithm
Based upon our analysis of bidirectional relationships, in particular, their effect on the
attractor structure of a BN, we have formulated an algorithm that limits the number of such
bidirectional relationships when predictor sets are chosen using the CoD method.
The algorithm’s input is the binary gene expression data. The outcome of the algo-
rithm is a BN with no non-singleton attractors. The following parameters are set in advance:
(1) a threshold, TCoD, for the CoD (TCoD = 0.7 in our study); (2) the maximum number,
MBR, of bidirectional relationships allowed (keeping in mind that, as we have shown, there
is a substantial probability of there being at least two genes with bidirectional relationships
in an arbitrary BN, MBR = 3 in our study); and (3) the minimum number, mA, of points
in the sample that appear as singleton attractors in the inferred BN (mA = 3 in our study).
Any predictor function that exceeds TCoD is called a high CoD predictor function. We now
describe the Singleton Attractor CoD (SA-CoD) algorithm.
Singleton Attractor CoD (SA-CoD) Inference Algorithm
1. Estimate the CoD and fi for all the combinations of predictor sets Wi, for i =
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1, 2, . . . , n.
2. Save all Wi and fi with CoD exceeding TCoD. For each target gene, save the high
CoD predictor sets and their associated predictor functions into two columns. The
length, Ci, i = 1, . . . , n, of both columns, depends on TCoD.
3. Form a BN from Wi and fi in step 2 such that the bidirectional relationships does not
exceed MBR. The algorithm never allows bidirectional relationships for connectivity
1 since this case guarantees the formation of non-singleton attractor cycles.
4. If there is a non-singleton attractor in the BN, then go to step 3; otherwise, continue.
5. If the number of data points appearing as singleton attractors in the BN is less than
mA, then go to step 3; otherwise, STOP.
The steps of the algorithm accomplish certain goals: step 3 limits bidirectional rela-
tionships, thereby limiting spurious attractor cycles resulting from bidirectional relation-
ships; step 4 checks to see if any non-singleton attractor cycles have “slipped through”
step 2; and step 5 insures that some minimal number of data points appears as singleton
attractors in the inferred BN. The algorithm does not guarantee that the inferred BN will
not contain singleton attractors that are not data points, but it does guarantee that there will
be no non-singleton attractors. It is spurious non-singleton attractors that are ubiquitous in
unconstrained CoD design. The algorithm does not guarantee that all data points will be
singleton attractors, although it guarantees a minimum number, mA, of these.
The algorithm can be run a number of times to produce a number of BNs, with each
data point appearing in one or more BNs as a singleton attractor. This is somewhat similar
to the design of PBNs under the requirement of contextual data consistency [33], where
every data point must appear as a singleton attractor in at least one constituent BN of the
PBN. There are, however, two key differences. First the method of [33] does not involve
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the CoD, but instead involves a constrained optimization relative to the data distribution in
the sample, and second, the number of BNs is determined by the data and it is theoretically
certain that each data point will appear in at least one of the BNs as a singleton attractor.
Nonetheless, the analogy is useful because the PBN design method first proposed in [5] ap-
plied CoD inference without constraint and then took combinations of high CoD predictor
functions to construct the BNs forming the PBN, with the threshold ultimately determining
the number of constituent BNs.
Regarding algorithm complexity, the total number of BNs that can be generated from
high CoD predictor functions is N =
∏n
i=1Ci, where n is the total number of genes and Ci
is the number of high CoD predictor functions. Thus, the search space has N members. In
worst-case scenario, step 3 will be repeated N times.
C. Results and Discussion
1. Comparison of SA-CoD Algorithm with Unconstrained CoD Design
We have applied the preceding BN design procedure using gene-expression profiles from
a study of 31 malignant melanoma samples explained in Chapter 1. The 7 genes used for
the model are pirin, WNT5A, S100P, RET1, MART1, HADHB and STC2 (this being their
order in the state space) and they were chosen from a set of 587 genes from the data-set
that have been subjected to an analysis of their ability to cross predict each other’s state in
a multivariate setting [21]. Table IV gives the 7-gene profiles for the 18 distinct data points
and their corresponding frequencies. The assumption is that the data points correspond to
the steady state of the underlying gene regulatory system.
The SA-CoD algorithm is applied 500 times to the gene expression data to generate
500 BNs. Based on the specifications of the algorithm, the BNs possess no non-singleton
attractors and there are at least three data points as singleton attractors in each of them. We
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Fig. 1. Light histogram shows the proportion of the steady-state mass outside the data states
in 1000 PBNs when the SA-CoD algorithm is used. Dark histogram shows the pro-
portion of the steady-state mass outside the data states in 1000 PBNs when the un-
constrained CoD method is used.
randomly choose 10 BNs from the pool of 500 BNs. Setting the perturbation probability
equal to 0.01, we generate a PBN from these 10 BNs. The PBN is run sufficiently long
so that its steady-state distribution can be estimated, and the proportion of the steady-state
mass lying outside the data states is computed. This procedure is repeated 1000 times to
generate 1000 PBNs, in each case the proportion of the steady-state mass outside the data
states being computed. These 1000 proportions are used to form the light histogram in
Figure 1. The mass of this histogram is concentrated very close to 0.
To compare the performance of the SA-CoD algorithm with the unconstrained CoD
method, we repeat the same experiment with the predictor sets and predictor functions with
high CoD chosen without the constraint of the SA-CoD algorithm. Proceeding without
constraint, 500 BNs are generated and 1000 PBNs composed of 10 BNs randomly chosen
from the 500 are generated and run into their steady states. The dark histogram in Figure 1
is formed from the proportions of mass of the 1000 steady-state distributions lying outside
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the data states. These are well dispersed between 0 and 0.35. By eliminating spurious
attractors, the SA-CoD algorithm puts a much higher concentration of the steady-state mass
on the data points.
A key issue for PBN design is to compose a PBN with enough BNs so that each data
state appears as an attractor in the PBN (that is, appears as a an attractor in one of the
constituent BNs) but not to include so many BNs that there is a large number of spurious
attractors. To compare the SA-CoD algorithm with unconstrained design in this regard,
in the next experiment we compare the number of data points appearing as attractors with
the number of attractors that are not data points in a collection of n BNs generated by the
either the SA-CoD algorithm or unconstrained CoD design. LetD be the number of distinct
points in the data, N be the number of data points appearing as attractors in the generated
BNs, and M be the number of non-data-point attractors appearing in the generated BNs. A
reasonable measure of performance for the desired comparison is:
R = a(D −N) + (1− a)M
where 0 ≤ a ≤ 1, a being chosen depending on what we want to emphasize. Smaller R
means better performance.
Since N and M are functions of the number n of BNs, R is a function of n. We
compute R(a, n) for n = 1, 2, ..., 80 and 0 ≤ a ≤ 1 by taking R(a, n) to be the average
of 1000 trials of computation of R, each trial involving randomly choosing n BNs from
a pool of 500 designed BNs. Figure 2(a) shows the surface graph of R(a, n) when using
the SA-CoD algorithm. The dots on the surface indicate the minimum value of R(a, n)
for a given value of a, the value of n for the minimum being the optimal number of BNs
relative to the measure R. For small a, the emphasis is on avoiding spurious attractors and
hence the optimum n is smaller. For large a, the emphasis is on recovering data points as
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attractors and hence the optimum n is larger.
The differences between Figure 2(a) and Figure 2(b) demonstrate the benefits of the
SA-CoD algorithm. First, we should point out the different scales of the graphs. The values
of R for unconstrained CoD design tend to greatly exceed those for the SA-CoD algorithm.
Second, in Figure 2(b), the optimal number of BNs is 1 for all but very large values of
a. This observation validates the point that, if we are concerned about spurious attractors,
then unconstrained CoD design performs poorly.
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Table IV. Expression profiles for melanoma.
Profile# Gene Count
pirin WNT5A S100P RET1 MART1 HADHB STC2
1 1 0 0 1 1 1 1 2
2 1 1 0 1 0 0 0 1
3 1 0 1 0 1 1 1 1
4 1 0 0 1 1 1 0 2
5 0 1 0 1 0 0 1 1
6 1 0 1 1 1 1 1 1
7 0 1 0 1 1 1 1 1
8 0 1 0 0 0 0 1 4
9 0 0 0 1 0 0 1 1
10 0 1 1 0 0 0 1 1
11 1 0 1 0 1 0 0 1
12 1 0 1 1 1 1 0 2
13 1 0 1 0 1 1 0 8
14 0 0 1 0 0 0 0 1
15 0 0 1 0 1 1 0 1
16 0 1 0 1 0 0 0 1
17 0 0 1 1 1 0 0 1
18 0 0 1 0 1 0 0 1
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(a)
(b)
Fig. 2. Value of R(a,n) for a from 0 to 1 and n from 1 to 80 (a) SA-CoD algorithm, (b)
unconstrained CoD method.
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CHAPTER IV
TIMING IN PROBABILISTIC BOOLEAN NETWORKS
A major concern of translational genomics is to use the knowledge of gene regulation to
design therapeutic strategies. Gene network modeling facilitates this effort by producing
dynamical systems to serve as the mathematical basis for the derivation of optimal interven-
tion strategies over time. To date, intervention has mainly focused on the external control
of probabilistic Boolean networks (PBNs) via the associated discrete-time discrete-space
Markov processes [11]. Given the accuracy of the model, there are two practical impedi-
ments to PBN-based intervention, both related to temporal issues. One of these concerns
the lack of information regarding the sojourn time in any given state and the other concerns
the practical problem of sampling. The first issue, the effect of sojourn time on the control,
has been studied in [37]. In this work, we focus on the effect of discrete sampling.
While the physical evolution of the biological gene network occurs over continuous
time, the PBN records only state transitions and contains no information on the time be-
tween transitions. The PBN model inherits this property from the original Boolean model,
from which it was generalized [3]. Hence, the problem can be explained in the frame-
work of the Boolean model. Fig. 3 shows the directed graph of a 3-gene Boolean net-
work, where each 3-gene state corresponds to a gene-activity profile (GAP). Fig. 4 shows
two continuous-time realizations that are equivalent from the perspective of the model of
Fig. 3. In both Fig. 4(a) and (b), the initial state is “100”. We observe the evolution
“100”→“010”→“001”, at which point there are no other changes because “001” is an at-
tractor of the network. While equivalent from the perspective of the Boolean model, from
the perspective of continuous time, the realizations of Fig. 4 (a) and (b) are not the same.
For instance, in the second realization, the sojourn time in state “010” is much longer than
in the first realization. If we are only interested in tracking the transitions, this may be of
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no concern. On the other hand, suppose we are considering intervention and penalizing
undesirable states. Then, if “010” is an undesirable state, the penalty should be greater in
the second realization; that is, the penalty needs to consider the sojourn time in a state. This
problem has been addressed in the framework of asynchronous PBNs by considering the
process to be defined over continuous time and treating it as a semi-Markov process [37].
000
010101
111
011 001
100
110
Fig. 3. Presentation of a directed graph for an arbitrary 3-gene Boolean network.
Whether one considers the original synchronous PBNs or asynchronous PBNs, imple-
mentation of the intervention policy requires nearly continuous observation because pre-
cise application requires the observation of all transitions. However, this is not generally
the case in medical applications; rather, as with many engineering problems, the process is
sampled at discrete time intervals and a decision to intervene or not must be made at each
sample point. Since the process is not observed outside the sample points, it is impossible
to know if, or how many, transitions have taken place between consecutive sample points.
In Fig. 4, the discrete-time process {Yn, n ≥ 0} given by Yn = Ztn is called the jump
chain of the continuous-time process {Zt, t ≥ 0}. Both synchronous and asynchronous
PBNs deal with the jump chain under the assumption that the jumps (i.e. t0, t1, . . . ) are
observed. The jump chains corresponding to realizations of Figs. 4(a) and (b) are equiv-
alent. Fig. 4 also shows the sampled processes corresponding to each realization. The
sampled process corresponding to Fig. 4(a) is “100”→“100”→“001”→“001”→“001”; for
Fig. 4(b), it is “010”→“010” →“001”→“001”→“001”. On account of sampling, “010” is
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Fig. 4. Two examples of temporal gene activity profiles (GAP) for Fig. 3. The dash-dot
vertical lines represent the sampling times.
missed in Fig. 4(a) and “100” is missed in Fig. 4(b). Whereas in a standard Boolean
network self-transitions only occur for singleton attractors, the sampled process has self-
transitions. Moreover, sojourn time is implicitly contained in the sampled process on ac-
count of these self-transitions. As with any sampling procedure, the sampling rate is cru-
cial. The faster the rate, the less transitions will be missed and the more accurate will be the
sojourn time estimates; the slower the rate, the more transitions will be missed and the less
accurate will be the sojourn time estimates. In any event, in the presence of sampling, nei-
ther the synchronous or asynchronous PBN models will adequately reflect the dynamics of
the network from the perspective of the decision process required for intervention. In this
chapter, we propose a framework for gene regulatory networks, a sampling-rate-dependent
PBN (SRD-PBN), that is capable of incorporating the sampling rate of temporal profile.
Below, we mathematically define SRD-PBNs and expose a methodology to obtain optimal
intervention strategies for such systems. We introduce SRD-PBNs in Section A. In Sec-
tion B, we derive an optimal policy for SRD-PBNs with various properties for synthetic
networks. We also consider a network obtained from melanoma gene-expression data.
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A. Sampling-Rate-Dependent Probabilistic Boolean Networks
A context-sensitive PBN disregards the information about the sojourn time in states present
in temporal data. From another point of view, a context-sensitive PBN models the jump
chain corresponding to the continuous-time process of interest. This means that in an ar-
bitrary temporal profile such as Fig. 5, the observer can only apply intervention at instants
t0, t1, . . . However, in medical applications, it is not known in advance when a transition
(i.e. a jump) will occur. As such, a model based on applying treatment when a transition
occurs may not conform with the reality and limitations of patient treatment. Time samples
and state changes are unlikely to coincide perfectly and an intervention strategy must focus
on the former not the latter.
Fig. 5. An example of temporal gene activity profiles
Our objective in this work is to propose a discrete-time discrete-space model based
on context-sensitive PBNs such that (i) it can embody the sojourn time of states into the
network dynamics, (ii) it allows us to incorporate the sampling rate into the network’s dy-
namics. A transition probability matrix must be derived for the state-space of a SRD-PBN
under specific assumptions. Similar to other Markovian models, the transition probability
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matrix derived for an SRD-PBN is sufficient to describe its dynamics. The task of find-
ing the most effective intervention strategy can then be formulated as a sequential decision
making problem via the associated transition probability matrix.
Let us first briefly introduce the underlying structure of an SRD-PBN. The states of the
SRD-PBN take values in S, as we defined for a context-sensitive PBN in Chapter II. Logi-
cal rules of different contexts determine the probability of jumps among GAPs. To coarsely
capture the rate of change in the underlying biological system, the proposed framework re-
quires two parameters, which are either known a priori or can be estimated from temporal
data. These two parameters are the maximum rate of change among GAPs and the maxi-
mum rate of change among contexts. The rate of change between any two states, i.e. the
average number of transitions between these two states in every unit of time, depends on
the probability of jumps between these two states, the sampling period, the maximum rate
of change among GAPs, and the maximum rate of change among contexts. Employing
these parameters, we construct a Q-matrix on the state-space S of the SRD-PBN. This ma-
trix is the generator of a continuous-time Markov chain. We are interested in the state of
the continuous process only at discrete observation instants. The memoryless property of
the continuous-time Markov chain allows us to model the dynamics of the sampled process
as a discrete-time Markov chain. The transition probability matrix of this Markov chain is
the transition probability matrix of the SRD-PBN. Below, we define the SRD-PBN in more
details.
Given Boolean functions of context c, the probability of jumping from state (c, x) to
state (c, x′) is
P(c,x),(c,x′) = p
D(x,x′)(1− p)n−D(x,x
′) + (1− p)n1 (fc(x) = x
′) , (4.1)
where p is the perturbation probability in the Boolean network. The Hamming distance be-
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tween GAPs x and x′ is denoted by D(x, x′). We use 1(·) to denote the indicator function.
The successor state of GAP x according to the Boolean functions of context c is denoted
by fc(x). The first part of (4.1) corresponds to the transition probability due to gene per-
turbation. The probability of transitioning between GAPs x and x′ based on the selected
context fc is presented as the second part of (4.1).
To include timing in our proposed model, given (4.1), we introduce matrix Q which
shows the rate of transitions among states in S. We denote the maximum rate of change
among GAPs by λ and the maximum rate of change among contexts by γ. In practice, λ
can be estimated from temporal data. Knowledge of the ratio λ
γ
, provided by experiments,
would determine the value of γ. Matrix Q is the generator of a continuous-time Markov
chain. Let Q = (q(c,x),(c′,x′); c, c′ ∈ {1, . . . , k}, x, x′ ∈ W) denote the Q-matrix of the
continuous-time Markov chain {Z(t), t ≥ 0} whose state-space is S. Elements of the Q-
matrix show the rate of change among states and can be computed in the following manner.
At any updating epoch, there are two independent processes: (i) a process that updates
the GAP in the current context, (ii) a process that updates the context. There is null proba-
bilities for both processes to occur at the same time. For the first process, we can compute
the rate of change among GAPs x and x′ in context c as the product of λ, the maximum rate
of change between GAPs, times the probability to jump from GAP x to x′, i.e. P(c,x),(c,x′).
For the second process, we can compute the rate of change between contexts c and c′ as the
product of γ, the maximum rate of change between contexts, times the selection probability
of context c′. Furthermore, in order to have a valid Q-matrix (2.7), all diagonal elements
of Q should be defined such that the sum of elements in each row is zero. Thus, the rate of
change between any two states (c, x) and (c′, x′) in S is defined as
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q(c,x),(c′,x′) =

λP(c,x),(c,x′) if c = c′ and x 6= x′,
γpc′ if c 6= c′ and x = x′,
0 if c 6= c′ and x 6= x′,
−
∑
X 6=x
∑
C 6=c q(c,x),(C,X) if c = c′ and x = x′,
(4.2)
where pc′ is the selection probability of context c′.
We define ptij to be the probability that the continuous-time process {Zt, t ≥ 0} asso-
ciated to the SRD-PBN makes a transition from current state i to successor state j after t
units of time. Using this notation, ptij corresponds to (i, j) entry in matrix P(t), where
P(t) = eQt.
From the intervention perspective, we are interested in the dynamical behavior of the
SRD-PBN at discrete observation instants, i.e. every T units of time. Such a discrete-time
model yields more information for the decision making process. Employing the memo-
ryless property of the continuous-time Markov chain, we obtain a discrete-time Markov
chain by taking samples from the continuous-time Markov chain at every T units of time.
This discrete-time model describes the dynamics of the SRD-PBN. For a given sampling
period T , the transition probability matrix that expresses the dynamics of the SRD-PBN is
computed as
P(T ) = eQT , (4.3)
where elements of Q are defined in (4.2). We note that the transition probability matrix
associated to the SRD-PBN is a function of the sampling period T . Optimal intervention
strategies can then be derived for this SRD-PBN using the corresponding transition proba-
bility matrix.
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Example: To illustrate the details of an SRD-PBN, we produce a simple 3-gene, 2-
context example. Given the logical rules of each constituent Boolean network, one can
draw the directed graphs corresponding to each Boolean network. Fig. 6 shows the di-
rected graphs of the constituent Boolean networks in our simple example. The transition
probability matrix corresponding to the context-sensitive PBN constructed based on these
Boolean networks is shown in Table V. This transition probability matrix is computed fol-
lowing the methodology described in [37]. The switching probability q is chosen to be 0.01
and there exists a gene perturbation probability of 0.01. It is clear that most of the states
have zero self-transition probabilities. To construct the transition probability matrix of the
SRD-PBN model, we first select λ and γ to be 0.1 and 0.05, respectively. The rate matrix
Q is computed based on (4.2). The transition probability matrix of the SRD-PBN corre-
sponding to this matrix Q for sampling period of T = 2 is computed based on (4.3) and
is shown in Table VI. A similar procedure is repeated for T = 4 and the transition prob-
ability matrix of the SRD-PBN is shown in Table VII. It is evident that the self-transition
probabilities in Tables VI and VII are not zero. These values are different for T = 2 and
T = 4. Intuitively, we expect a higher self-transition probability for a smaller sampling
period and a lower self-transition probability for a larger sampling period. It can be seen
that self-transition probabilities are larger in Table VI for T = 2 compared to Table VII for
T = 4.
B. Results and Discussion
Our prime goal of modeling gene regulatory networks from temporal gene expression data
is to derive effective intervention strategies and beneficially alter the long-run behavior of
the inferred model. From a practical point of view, at every observation point, this strategy
decides which action should be applied to the underlying biological system. Provided that
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(a) (b)
Fig. 6. Directed graphs of Boolean networks corresponding to the toy example
the model framework captures the dynamics of gene regulatory networks accurately, the
derived intervention strategy would favorably alter the behavior of aberrant cells.
In this section, through numerical studies, we provide supporting evidence for the need
to extend the original PBN framework. In the following simulations, the target gene, the
gene responsible for aberrant behavior of the cell, is chosen to be the most significant gene
in the GAP. We assume the up-regulation of the target gene is undesirable. Consequently,
the state-space is partitioned into desirable states, D, and undesirable states, U . Since our
objective is to down-regulate the target gene, a higher cost is assigned to destination states
having an up-regulated target gene. Moreover, for a given status of the target gene for a
destination state, a higher cost is assigned when the control is applied, versus when it is
not. In practice, the cost values will have to mathematically capture the benefits and costs
of intervention and the relative preference of states. These cost values will eventually be
set with the help of physicians in accordance with their clinical judgement. Although this
is not feasible within current medical practice, we do believe that such an approach will
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Table V. Transition probability matrix of the context-sensitive PBN
0 0.73507 0.0073508 7.425e-005 0.0073508 7.425e-005 7.425e-005 7.5e-007 0 0.24502 0.0024503 2.475e-005 0.0024503 2.475e-005 2.475e-005 2.5e-007
0.0073508 0.72772 7.425e-005 0.0073508 7.425e-005 0.0073508 7.5e-007 7.425e-005 0.0024503 0 2.475e-005 0.0024503 2.475e-005 0.0024503 2.5e-007 0.2426
0.0073508 7.425e-005 0 0.0073508 7.425e-005 0.72773 0.0073508 7.425e-005 0.0024503 0.2426 0 0.0024503 2.475e-005 2.5e-007 0.0024503 2.475e-005
7.425e-005 0.73507 0.0073508 0 7.5e-007 7.425e-005 7.425e-005 0.0073508 2.475e-005 0.0024503 0.0024503 0.24257 2.5e-007 2.475e-005 2.475e-005 0.0024503
0.73507 7.425e-005 7.425e-005 7.5e-007 0 0.0073508 0.0073508 7.425e-005 0.24502 2.475e-005 2.475e-005 2.5e-007 0 0.0024503 0.0024503 2.475e-005
0.7278 0.0073508 7.5e-007 7.425e-005 0.0073508 0 7.425e-005 0.0073508 2.475e-005 0.0024503 2.5e-007 2.475e-005 0.0024503 0 0.2426 0.0024503
7.425e-005 7.5e-007 0.0073508 7.425e-005 0.73507 7.425e-005 0 0.0073508 0.2426 2.5e-007 0.0024503 2.475e-005 0.0024503 2.475e-005 0 0.0024503
0.72773 7.425e-005 7.425e-005 0.0073508 7.425e-005 0.0073508 0.0073508 0 2.5e-007 2.475e-005 0.2426 0.0024503 2.475e-005 0.0024503 0.0024503 0
0 0.24502 0.0024503 2.475e-005 0.0024503 2.475e-005 2.475e-005 2.5e-007 0 0.73507 0.0073508 7.425e-005 0.0073508 7.425e-005 7.425e-005 7.5e-007
0.0024503 0.24257 2.475e-005 0.0024503 2.475e-005 0.0024503 2.5e-007 2.475e-005 0.0073508 0 7.425e-005 0.0073508 7.425e-005 0.0073508 7.5e-007 0.7278
0.0024503 2.475e-005 0 0.0024503 2.475e-005 0.24258 0.0024503 2.475e-005 0.0073508 0.7278 0 0.0073508 7.425e-005 7.5e-007 0.0073508 7.425e-005
2.475e-005 0.24502 0.0024503 0 2.5e-007 2.475e-005 2.475e-005 0.0024503 7.425e-005 0.0073508 0.0073508 0.72772 7.5e-007 7.425e-005 7.425e-005 0.0073508
0.24502 2.475e-005 2.475e-005 2.5e-007 0 0.0024503 0.0024503 2.475e-005 0.73507 7.425e-005 7.425e-005 7.5e-007 0 0.0073508 0.0073508 7.425e-005
0.2426 0.0024503 2.5e-007 2.475e-005 0.0024503 0 2.475e-005 0.0024503 7.425e-005 0.0073508 7.5e-007 7.425e-005 0.0073508 0 0.7278 0.0073508
2.475e-005 2.5e-007 0.0024503 2.475e-005 0.24502 2.475e-005 0 0.0024503 0.7278 7.5e-007 0.0073508 7.425e-005 0.0073508 7.425e-005 0 0.0073508
0.24258 2.475e-005 2.475e-005 0.0024503 2.475e-005 0.0024503 0.0024503 0 7.5e-007 7.425e-005 0.7278 0.0073508 7.425e-005 0.0073508 0.0073508 0
Table VI. Transition probability matrix of SRD-PBN for sampling period T = 2
0.37738 0.29685 0.0025193 0.0008308 0.0022317 0.0014735 4.8756e-005 0.0026109 0.17417 0.11432 0.0040765 0.00044188 0.0010277 0.00048008 0.0001188 0.021425
0.0051341 0.66138 0.0014114 0.0030301 5.637e-005 0.0031601 6.0717e-005 0.0097065 0.0015781 0.23749 0.011406 0.0016716 2.2949e-005 0.0013831 0.0003802 0.062127
0.062988 0.025801 0.37564 0.002299 0.0015365 0.21034 0.003429 0.0019038 0.01262 0.054741 0.17501 0.0013961 0.00037188 0.050619 0.010816 0.010485
0.0018478 0.28873 0.002432 0.38578 2.3813e-005 0.0014393 4.4532e-005 0.0036407 0.00040847 0.063794 0.00299 0.2356 6.0167e-006 0.00036679 8.8608e-005 0.012803
0.22187 0.079318 0.00072494 0.00015764 0.37664 0.0024982 0.002244 0.00048444 0.10249 0.031863 0.00084154 8.1732e-005 0.17387 0.0011084 0.0012378 0.0045695
0.21324 0.079173 0.00070957 0.00018836 0.0040734 0.37565 0.0083255 0.002574 0.060811 0.024153 0.00092305 8.5038e-005 0.0014544 0.17354 0.050526 0.0045683
0.071732 0.017277 0.0024065 6.3607e-005 0.21273 0.0013257 0.376 0.0024078 0.070736 0.014919 0.0015871 4.9862e-005 0.051673 0.00034222 0.17372 0.0030368
0.21154 0.077929 0.0089785 0.002416 0.0012851 0.0036983 0.0022689 0.37582 0.051094 0.031437 0.051227 0.0014448 0.00031749 0.001226 0.0013476 0.17797
0.17565 0.12565 0.0024739 0.00039997 0.0010368 0.00074174 6.7046e-005 0.010044 0.37689 0.22611 0.014053 0.00099915 0.0022213 0.00084704 0.00032511 0.062497
0.011417 0.23929 0.0098272 0.001504 8.64e-005 0.0027633 0.00034266 0.050829 0.0039058 0.39764 0.060426 0.003911 5.5836e-005 0.0030169 0.001496 0.21348
0.012655 0.064714 0.17491 0.0014051 0.00035111 0.050907 0.0011899 0.0099297 0.0050204 0.21462 0.38697 0.0038826 0.00010197 0.009037 0.003685 0.060622
0.0004758 0.076766 0.0013999 0.23545 6.5807e-006 0.00040455 2.2788e-005 0.0015328 0.00012971 0.015123 0.0040482 0.65904 1.9695e-006 0.00011107 6.8701e-005 0.0054156
0.10266 0.035066 0.000488 7.4731e-005 0.17398 0.001155 0.0011304 0.0015062 0.22178 0.065926 0.0024392 0.00018174 0.37605 0.0023679 0.002877 0.012319
0.062368 0.016439 0.00047643 4.6578e-005 0.011113 0.17357 0.050527 0.0015158 0.069453 0.017142 0.0018487 8.9707e-005 0.0041756 0.37542 0.2103 0.0055079
0.061308 0.02493 0.0015044 7.6473e-005 0.051743 0.00043038 0.17358 0.0024897 0.21367 0.063818 0.0051748 0.00022306 0.011114 0.00023948 0.37546 0.014239
0.052715 0.023646 0.050781 0.0014047 0.00037883 0.010866 0.0013362 0.17493 0.010096 0.063371 0.21202 0.0038826 0.00010502 0.0035566 0.0036239 0.38728
become feasible when engineering approaches are integrated into translational medicine.
We postulate the following cost-per-stage in state j under control u:
g(u, j) =

0 if u = 0 and j ∈ D,
5 if u = 0 and j ∈ U ,
c if u = 1 and j ∈ D,
5+c if u = 1 and j ∈ U ,
(4.4)
where c denotes the cost of control. We study the effect of c in our simulations. A cost
minimization framework is used to effectively trade-off the number of interventions and
the likelihood of the network being in an undesirable state. An optimal control policy with
regard to the cost values can be found via dynamic programming.
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Table VII. Transition probability matrix of SRD-PBN for sampling period T = 4
0.17868 0.35925 0.0057011 0.0019278 0.0021134 0.0035642 0.00021701 0.016212 0.1333 0.20118 0.020986 0.0018779 0.0015748 0.0017692 0.00074308 0.070901
0.014692 0.50027 0.0090648 0.0040594 0.00019922 0.0057762 0.00043069 0.033177 0.0050446 0.25957 0.040292 0.0041558 8.4702e-005 0.0031117 0.0015077 0.11857
0.10288 0.090581 0.17324 0.0026056 0.0041568 0.1762 0.0090185 0.0089919 0.040905 0.10373 0.14019 0.003032 0.0014774 0.076391 0.030785 0.035828
0.0057851 0.33727 0.004429 0.20531 8.54e-005 0.0031632 0.00016202 0.011467 0.0018686 0.12417 0.013755 0.24697 3.2803e-005 0.0013484 0.00053547 0.043661
0.20516 0.17535 0.0022614 0.00067721 0.17329 0.0032648 0.0022213 0.0054509 0.15542 0.10424 0.0073772 0.00063446 0.13147 0.0021403 0.002346 0.028711
0.18835 0.1639 0.0021694 0.00066995 0.010183 0.17221 0.02385 0.0063215 0.10749 0.082778 0.0066183 0.00056804 0.003877 0.13076 0.076045 0.024191
0.13102 0.075247 0.003231 0.00029166 0.17834 0.0026047 0.17213 0.0048031 0.13651 0.061893 0.0059905 0.00034666 0.078014 0.0012002 0.1312 0.017175
0.1811 0.16663 0.025842 0.0030037 0.0022348 0.010116 0.0023946 0.17635 0.078679 0.10179 0.082779 0.0033655 0.00096658 0.0034649 0.0029033 0.15838
0.14216 0.24037 0.010431 0.001545 0.0016752 0.0039442 0.00038594 0.031819 0.17574 0.23275 0.04076 0.0026171 0.0020726 0.0021998 0.0012051 0.11032
0.035076 0.27152 0.029857 0.0033663 0.00049728 0.011092 0.0012222 0.079698 0.011315 0.24615 0.099865 0.0060475 0.00018346 0.0050184 0.0032555 0.19583
0.041474 0.13533 0.13886 0.003053 0.0013976 0.078705 0.0032107 0.030301 0.014961 0.20188 0.20765 0.0058504 0.00046527 0.025556 0.0099638 0.10134
0.0023676 0.17371 0.0032769 0.24628 3.8474e-005 0.0016271 8.52e-005 0.0049515 0.00071434 0.05067 0.0082044 0.49004 1.2965e-005 0.00055224 0.00024337 0.017234
0.15752 0.12513 0.0030728 0.00053267 0.13185 0.0026918 0.0019382 0.0096008 0.20416 0.12842 0.012724 0.00086452 0.17237 0.0027507 0.0033873 0.042997
0.11652 0.069673 0.0020666 0.00028091 0.03164 0.13106 0.075975 0.0051168 0.12448 0.05981 0.0065406 0.00039252 0.010492 0.17138 0.17558 0.01899
0.11116 0.094641 0.0045875 0.00047552 0.078157 0.001985 0.13066 0.010669 0.19213 0.11775 0.015097 0.00087665 0.026864 0.0010117 0.17157 0.042379
0.088771 0.087311 0.078238 0.0030548 0.0013755 0.031372 0.0027699 0.13944 0.029664 0.11819 0.18652 0.0058631 0.00046275 0.0095599 0.005974 0.21143
In our simulation studies, our objective is to show that an optimal policy derived for
the current definition of context-sensitive PBN will no longer be optimal if we include
the timing information of temporal data into the dynamics of gene regulatory networks. To
this end, we generate synthetic SRD-PBNs and corresponding context- sensitive PBNs. We
compute the cost induced by the optimal policy derived for the context-sensitive PBN and
the cost induced by the optimal policy derived for the SRD-PBN, when both are applied
to a sequence of data generated from the SRD-PBN. These two cost values are compared
in our simulation studies. An SRD-PBN accommodates the sampling rate, which is in
this simulation identical to the intervention rate. The goal of this study is to measure how
costly it is to apply an optimal policy derived for a context-sensitive PBN to a sequence
of data generated based on an SRD-PBN. In the following, we first consider synthetically
generated SRD-PBNs. Furthermore, we study the gene regulatory network inferred from
metastatic melanoma gene expression data.
1. Synthetic Networks
We generate SRD-PBNs in the following manner. Each SRD-PBN consists of 2 constituent
Boolean networks. Each Boolean function of a Boolean network is randomly generated
with a random bias. Given a set of Boolean networks, we generate various SRD-PBNs.
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We let γ = 0.01. We vary the value of λ from 0.05 to 4 with step-size 0.2. We choose
the gene perturbation probability of 0.01. The constituent Boolean networks are selected
with equal probabilities. Furthermore, for the given set of Boolean networks, we generate
the corresponding context sensitive PBNs for switching probability q = 0.01. We let the
observation period to be every 1 unit of time, i.e. T = 1.
Using dynamic programming, given the cost-per-stage defined in (4.4), we derive an
optimal intervention policy µ∗srd for an SRD-PBN. Our goal is to estimate the average total
discounted cost induced by µ∗srd for a sequence of data generated from the SRD-PBN. To
this end, we generate synthetic time-course data for 1000 time-steps from the SRD-PBN
model while µ∗srd is applied. We estimate the discounted cost by accumulating the dis-
counted cost of each state given the action at that state. This procedure is repeated 10, 000
times for random initial states and the average of the induced discounted cost is computed.
Likewise, an optimal policy µ∗cs for a context-sensitive PBN is derived. Following a similar
procedure, µ∗cs is applied to the SRD-PBN, which we already described, and the average
discounted cost is computed. Moreover, we compute the average discounted cost of a se-
quence of time-course data for an SRD-PBN in the absence of intervention.
In summary, for each set of Boolean networks, we have the following: (C¯srd) av-
erage total discounted cost induced by µ∗srd on the SRD-PBN; (C¯cs) average total dis-
counted cost induced by µ∗cs on the SRD-PBN; (C¯woc) average total discounted cost in-
duced in the absence of any intervention on SRD-PBN. The preceding procedure is re-
peated for 1000 random Boolean networks, thereby yielding 1000 values for each statistic:
C¯srd1 , . . . , C¯
srd
1000; C¯
cs
1 , . . . , C¯
cs
1000; C¯
woc
1 , . . . , C¯
woc
1000.
Using these, we compare the effect of µ∗srd and µ∗cs on an SRD-PBN by the em-
pirical averages M[Csrd] of C¯srd1 , . . . , C¯srd1000; M[Ccs] of C¯cs1 , . . . , C¯cs1000; and M[Cwoc] of
C¯woc1 , . . . , C¯
woc
1000. We define the gain obtained by each intervention policy as the differ-
ence between the average discounted cost before and after intervention. Gsrd, the gain of
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policy µ∗srd, is M[Cwoc]−M[Csrd] and Gcs, the gain of policy µ∗cs applied to an SRD-PBN,
is M[Cwoc]−M[Ccs]. We are interested in M[Ccs]−M[Csrd], which we refer to as ∆G.
Figs. 7, 8, and 9 demonstrate the outcome of the above experiment for various values
of cost of control c. It is evident that the intervention gains Gsrd and Gcs are larger for
smaller cost of intervention. The structure of a context-sensitive PBN is such that there is a
transition to a new state after each unit of time, which corresponds to one change at every
unit of time on average. When λ is substantially smaller or larger than 1, ∆G is larger
compare to the case where λ is closer to 1, as is shown in Figs. 7, 8, 9. We should point
out that the value of λ for which ∆G attains its minimum depends on many factors, such
as γ, the switching probability q in context-sensitive PBN, and the cost of control. It is also
observed that ∆G increases for larger cost of control.
We emphasize that this simulation study compares the gains obtained by two policies,
the policy optimal for the SRD-PBN and the policy optimal for the context-sensitive PBN,
when each is applied to SRD-PBN. Our objective is to show how poor the effect of an in-
tervention policy derived for a context-sensitive PBN might be if the rate of change among
observations is substantially different from 1.
2. Melanoma Gene Expression
In this section, we consider the gene network corresponding to metastatic melanoma ex-
plained in Chapter II. We postulate the cost-per-stage in (4.4) with the cost of control c
being 0.1. Since our objective is to down-regulate the WNT5A gene, a higher penalty is
assigned for destination states having WNT5A up-regulated. Also, for a given WNT5A sta-
tus for the destination state, a higher penalty is assigned when the control is active versus
when it is not.
We generate the SRD-PBN corresponding to the melanoma-based data. Similar to the
procedure explained in the previous section, we compute µ∗cs and µ∗srd. Both policies are
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Fig. 7. (a) Gsrd, gain obtained by the policy optimal for SRD-PBN, and Gcs, the gain ob-
tained by the policy optimal for context-sensitive PBN, when both are applied to
SRD-PBN for various λ. (b) Difference between the gains, ∆G, for various λ. The
cost of control is 0.1.
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Fig. 8. (a) Gsrd, gain obtained by the policy optimal for SRD-PBN, and Gcs, the gain ob-
tained by the policy optimal for context-sensitive PBN, when both are applied to
SRD-PBN for various λ. (b) Difference between the gains, ∆G, for various λ. The
cost of control is 1.0.
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Fig. 9. (a) Gsrd, gain obtained by the policy optimal for SRD-PBN, and Gcs, the gain ob-
tained by the policy optimal for context-sensitive PBN, when both are applied to
SRD-PBN for various λ. (b) Difference between the gains, ∆G, for various λ. The
cost of control is 3.
applied to a sequence of data generated from the SRD-PBN and the cost corresponding to
the policy is estimated. Fig. 10 shows the outcome of this experiment. Similar results
are observed as λ varies. We should emphasize that Fig. 10 corresponds to one network
representing the melanoma gene expression data while Figs. 7, 8, and 9 consider average
behavior of 1000 synthetically generated networks.
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Fig. 10. Simulation results corresponding to Melanoma study (a) Gsrd, gain obtained by the
policy optimal for SRD-PBN, and Gcs, the gain obtained by the policy optimal
for context-sensitive PBN, when both are applied to SRD-PBN for various λ. (b)
Difference between the gains, ∆G, for various λ. The cost of control is 0.1.
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CHAPTER V
OPTIMAL CYCLIC CONTROL POLICY∗
Successful treatment of bacterial infections is largely a result of our ability to exploit the
biochemical differences between bacteria and human cells so as to achieve toxic drug con-
centrations in the former while sparing the latter. Unfortunately, such high selectivity is at
present elusive in the chemotherapy of human cancers. Hence, great efforts are required
to determine dose schedules that maximize the benefit to toxicity ratio in cancer treatment
[14]. To this end, chemotherapy is generally given in cycles: each treatment is followed by
a recovery phase. During a recovery period, the side effects tend to gradually subside. Dose
intensity is a measure of chemotherapy delivery that looks at the amount of drug delivered
per unit of time. A higher drug dose intensity can be delivered by increasing the dose per
cycle (dose escalation) or by reducing the interval between cycles (dose density).
For a given integrated drug effect, the chance of eradicating the tumor is maximized
by delivering the most effective dose level of drug over as short a time as possible. Tumors
given less time to grow between treatments are more likely to be eradicated. Administering
high quantities of drugs at the beginning of a chemotherapy cycle might fail for two reasons.
First, levels higher than a certain concentration may not increase the killing rate of cancer
cells. Second, even if they did, the toxicity could be intolerable to the patient. In practice,
optimizing the schedule means determining a way to give the maximum integrated effect
over as short a time as possible, consistent with reasonable quality of life [14].
A prime objective of modeling genetic regulatory networks is to develop therapies
based on gene regulation, in particular, the disruption or mitigation of aberrant gene func-
∗ Reprinted with permission from “Optimal Intervention Strategies for Cyclic Ther-
apeutic Methods” by G. Vahedi, B. Faryabi, J.-F. Chamberland, A. Datta, and E. R.
Dougherty, 2009, IEEE Transactions on Biomedical Engineering, 56, 281-291, Copyright
2009 by IEEE.
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tion contributing to the pathology of a disease. Engineering therapeutic tools involve syn-
thesizing nonlinear dynamical networks, analyzing these networks to characterize gene
regulation, and developing intervention strategies to modify dynamical behaviors [38]. In
this chapter, we derive an optimal cyclic intervention strategy for gene regulation in the
context of probabilistic Boolean networks.
For intervention strategies proposed earlier [10, 11, 39, 16], at every state transition
of the system, the intervention strategy dictates whether to apply treatment or not. In this
chapter, our objective is to devise an effective intervention strategy under the constraint that
intervention is permitted only every W transitions, where W ∈ N denotes the length of the
recovery period. An intervention strategy that is optimal for the case where intervention is
permitted at every transition is not necessarily optimal (i.e. may not minimize the expected
total discounted cost) if one is only permitted to apply treatment every W transitions. We
will refer to a policy that is optimal when intervention is permitted every transition as
an optimal one-transition policy. Similarly, we refer to the policy that is optimal when
intervention is permitted every W transitions as an optimal W-transition policy.
We define a treatment window to be every W transitions of the system. Intervention
is permitted at the beginning of a treatment window. Thereafter, the system transitions
W − 1 steps without intervention. To incorporate the cyclic constraint on interventions,
we construct a Markov chain with an augmented state space based on the original Markov
chain. An optimal cyclic intervention policy, i.e. optimal W-transition policy, can be found
by solving the stochastic control problem for the Markov chain with the augmented state
space via dynamic programming algorithms. However, this procedure maybe prohibitive
due to the size of the augmented state space. We show that the augmented state space
can be collapsed resulting in a compressed space of size equal to the original state space.
We accomplish this reduction in the size of the state space by accumulating the expected
cost of the system progressing during a period. The new cost function is used to select the
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proper action when intervention is permitted. We establish the convergence of the dynamic
programming algorithm and show how the optimal W-transition intervention strategy can
be found. Furthermore, we compare the performance of an optimal W-transition policy to
that of an optimal one-transition policy when intervention is applied every W transitions.
We show that although this may not be true in general, in our intervention framework,
optimal one-transition policy can be used as an approximation of optimal W-transition
policy.
A. Optimal Control Strategy for Cyclic Therapeutic Methods
Our objective is to find an effective intervention policy when we are allowed to apply treat-
ment only every W transitions, in other words at times t = 0,W, 2W, . . . To incorporate
this cyclic constraint in our mathematical framework, we construct a Markov chain with
an augmented state space based on the original Markov chain. The new (augmented) state
space is defined as
S˜ = {(i, j)|i ∈ {0, . . . , N − 1}, j ∈ {0, . . . ,W − 1}},
where N is the size of the original state space S. There are two types of states in the
augmented state space: state (i, j) with j = 0, represented as (i, 0), where intervention is
permitted, and state (i, j) with j 6= 0, where intervention is not permitted. In the augmented
state space, the control u is constrained to take values in U(i, j), a given nonempty subset
of C. For the first type of states, (i, 0), we have U(i, 0) = {0, 1}, while for the second type
of states, (i, j) where j 6= 0, we have U(i, j) = {0}.
The transition probabilities in the augmented state space are defined as a function of
control u. For state (i, 0), we define the probability of transitioning to state (i′, j′) given
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control u as
p(i,0)(i′,j′)(u) =
 pi,i′(u) if j
′ = 1,
0 otherwise,
where pi,i′(u) denotes the probability of transitioning from state i to state i′ under control u.
On the other hand, for states (i, j) where j 6= 0, control u only admits one value, u ∈ {0}.
For these states, the transition probability is defined as
p(i,j)(i′,j′)(u = 0) =
 pi,i′(u = 0) if j
′ = (j + 1) mod W
0 otherwise,
where pi,i′(u = 0) = pi,i′ denotes the uncontrolled probability of transitioning from state
i to state i′. It should be noted that (j′ = (j + 1) mod W ) is true if either (j′ = j + 1)
or (j = W − 1 and j′ = 0) is true. Considering that u ∈ U(i, j), the probability of
transitioning from state (i, j) to state (i′, j′) can be compactly defined as
p(i,j)(i′,j′)(u) =
 pi,i′(u) if j
′ = (j + 1) mod W,
0 otherwise.
(5.1)
Let us now consider an example to explain how the above definition simulates the
cyclic intervention scenario. Assume that at time t = 0 we observe state i. At this time,
we are allowed to apply control u ∈ {0, 1}. The augmented state corresponding to state i
at time t = 0 is (i, 0). From augmented state (i, 0), under control u, the system transitions
to the augmented state (i′, 1) with probability pi,i′(u), where u ∈ {0, 1}. The probability
of transitioning to any other state (i′, j), where j 6= 1, is zero. At time t = 1 and from
augmented state (i′, 1), the system transitions to state (i′′, 2) with probability pi′,i′′(0) since
u ∈ {0}. Likewise, one can consider transitions for t = 2, . . . ,W − 2. Similarly, assume
that we observe state k at time t = W−1. The probability of transitioning to the augmented
state (k′, 0) is pk,k′(0). The probability of transitioning to any other state (k′, j), where
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j 6= 0, is zero.
The cost-per-stage for transitioning from augmented state (i, j) to augmented state
(i′, j′), given control u, is defined as
g(i, j, i′, j′, u) =
C + c i′ ∈ U and {j = 0 and j′ = 1} and u = 1,
C i′ ∈ U and {j′ = (j + 1) modW} and u = 0,
c i′ ∈ D and {j = 0 and j′ = 1} and u = 1,
0 i′ ∈ D and {j′ = (j + 1) mod W} and u = 0,
0 otherwise,
(5.2)
where C and c represent the cost of undesirable states and the cost of treatment (control),
respectively. Given u = 1, we assign a cost to a transition from state (i, j) to state (i′, j′)
only when j = 0 and j′ = 1. In this case, if i′ is an undesirable state, the corresponding
cost is C + c; if i′ is a desirable state, the only cost incurred is c. When u = 0, it is possible
to transition to (i′, j′) if j′ = (j + 1) mod W is true. In this case, if i′ is an undesirable
state, the corresponding cost is C; if i′ is a desirable state, no cost is incurred. For all the
other cases, no cost is assigned.
Based on (5.2), we define the expected immediate cost at state (i, j) when control u is
selected by
g(i, j, u) =
N−1∑
i′=0
W−1∑
j′=0
p(i,j)(i′,j′)(u)g(i, j, i
′, j′, u)
=
N−1∑
i′=0
[p(i,j)(i′,0)(u)g(i, j, i
′, 0, u)+
· · ·+ p(i,j)(i′,W−1)(u)g(i, j, i
′,W − 1, u)].
In this equation, for each value of i′, only one term inside the brackets is non-zero (based
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on the definition of the transition probabilities in (5.1)). Hence,
g(i, j, u) =
N−1∑
i′=0
p(i,i′)(u)g(i, j, i
′, j′, u),
where j′ = (j + 1) mod W is true. Using the definition of g(i, j, i′, j′, u) in (5.2), we have
g(i, j, u) =
 C
∑
i′∈U pi,i′(u = 1) + c if u = 1,
C
∑
i′∈U pi,i′(u = 0) if u = 0.
(5.3)
From (5.3), it is clear that g(i, j, u) does not depend on j, i.e. g(i, j, u) = g(i, u).
As we explained in Chapter II, the dynamic programming algorithm captures how the
optimal cost at Jk+1 propagates backward in time to the optimal cost Jk. For the augmented
state space, we have
Jk(i, j) = min
u∈ U(i,j)
[
g(i, j, u) + λ
N−1∑
i′=0
W−1∑
j′=0
p(i,j)(i′,j′)(u) Jk+1(i
′, j′)
]
∀(i, j) ∈ S˜.
(5.4)
Since g(i, j, u) = g(i, u), we can rewrite (5.4) as
Jk(i, j) = min
u∈ U(i,j)
[
g(i, u) + λ
N−1∑
i′=0
W−1∑
j′=0
p(i,j)(i′,j′)(u) Jk+1(i
′, j′)
]
,
∀(i, j) ∈ S˜.
(5.5)
Our goal is to derive the value functions for the original state space, i.e. S, based
on (5.5). To this end, for every treatment window starting with i ∈ S, we accumulate the
total discounted cost of all states in the window where no control can be applied and add
it to the average cost of state i. We then show how the accumulated cost at the beginning
of the (s + 1)th window affects the accumulated cost at the beginning of the sth window,
where s = 0, 1, 2, . . . This approach is in accord with the dynamic programming technique
that ranks decisions based on the sum of the present cost and the expected future cost,
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assuming optimal decision making for subsequent stages. This manipulation of the value
function lets us collapse the augmented state space S˜ to the much smaller space S. We
prove the convergence of the discounted cost algorithm in this framework and show how
an optimal W-transition control policy can be found using standard dynamic programming
algorithms.
Assume P is the transition probability matrix of the uncontrolled Markov chain. For
i, j ∈ S, let p(r)i,j be the probability of going from state i to state j in r steps, i.e. the (i, j)th
entry of the matrix P(r). The objective is to compute the recursive relation of the value
function starting at time t = sW , given the cost value at time t = (s+ 1)W .
Without loss of generality, we assume s = 0. In the augmented state space S˜, we are
not allowed to apply any control at state (i,W − 1), hence from (5.1) and (5.5)
JW−1(i,W − 1) = min
u∈U(i,W−1)
{
g(i, u) + λ
N−1∑
j=0
pi,j(u)JW (j, 0)
}
= g(i, 0) + λ
N−1∑
j=0
pi,jJW (j, 0).
(5.6)
Given JW−1, one can compute JW−2 as
JW−2(i,W − 2) = min
u∈U(i,W−2)
{
g(i, u) + λ
N−1∑
j=0
pi,j(u)JW−1(j,W − 1)
}
= g(i, 0) + λ
N−1∑
j=0
pi,jJW−1(j,W − 1).
Replacing JW−1 from (5.6), we have JW−2(i,W − 2) as a function of JW (k, 0) for all
k ∈ S,
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JW−2(i,W − 2) = g(i, 0) + λ
N−1∑
j=0
pi,j
(
g(j, 0) + λ
N−1∑
k=0
pj,kJW (k, 0)
)
= g(i, 0) + λ
N−1∑
j=0
pi,jg(j, 0) + λ
2
N−1∑
k=0
p
(2)
i,kJW (k, 0).
Similarly we can compute JW−3 as
JW−3(i,W − 3) =
N−1∑
j=0
(
p
(0)
i,j + λp
(1)
i,j + λ
2p
(2)
i,j
)
g(j, 0) + λ3
N−1∑
k=0
p
(3)
i,kJW (k, 0).
One can recursively evaluate the value function for the last state in a treatment window
where no control is allowed, i.e. J1(i, 1), as follow:
J1(i, 1) =
N−1∑
j=0
(
W−2∑
r=0
λrp
(r)
i,j
)
g(j, 0) + λW−1
N−1∑
k=0
p
(W−1)
i,k JW (k, 0). (5.7)
Finally, at time 0, intervention is allowed and the following minimization problem leads to
J0(i, 0) = min
u∈U(i,0)
{
g(i, u) + λ
N−1∑
j=0
pi,j(u)J1(j, 1)
}
. (5.8)
Using (5.7) and (5.8), we obtain
J0(i, 0) = min
u∈U(i,0)
{
g(i, u) + λ
N−1∑
j=0
pi,j(u)
(
N−1∑
k=0
(
W−2∑
r=0
λrp
(r)
j,k
)
g(k, 0)
+λW−1
N−1∑
k=0
p
(W−1)
j,k JW (k, 0)
)}
.
(5.9)
We can rewrite (5.9) as
JsW (i, 0) = min
u∈U(i,0)
{g(i, u) +λ
N−1∑
j=0
pi,j(u)
(
N−1∑
k=0
(
W−2∑
r=0
λrp
(r)
j,k
)
g(k, 0)
+λW−1
N−1∑
k=0
p
(W−1)
j,k J(s+1)W (k, 0)
)}
,
(5.10)
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for s = 0, 1, 2, . . . This equation reveals how the cost at the beginning of the (s + 1)th
window affects the cost at the beginning of the sth window. This equation ranks decisions
based on the sum of the present cost and the expected future cost considering the cost of
all the states where no control is allowed between two treatment times. This manipulation
of the value function lets us collapse the state space from S˜ to S and leads to
Js(i) = min
u∈U(i)
{
g(i, u) + λ
N−1∑
j=0
pi,j(u)
(
N−1∑
k=0
(
W−2∑
r=0
λrp
(r)
j,k
)
g(k, 0)
+λW−1
N−1∑
k=0
p
(W−1)
j,k J(s+1)(k)
)}
,
(5.11)
for s = 0, 1, 2, . . . It should be noted that the above backward propagation of costs applies
to every W transitions of the Markov chain in which we are permitted to apply intervention
and U(i) = {0, 1}.
Similar to Chapter II, the following proposition discusses how an optimal W-transition
stationary control policy can be devised. In Proposition 6, we prove the convergence of the
discounted cost algorithm as it is defined in this work. Propositions 2 and 3 can be restated
for the following operator T .
Proposition 6 (Convergence of the discounted cost algorithm): For any i ∈ S, bounded
function J : S 7→ ℜ, and T : S 7→ ℜ, where
TJ(i) = min
u∈U(i)
{
g(i, u) + λ
N−1∑
j=0
pi,j(u)
(
N−1∑
k=0
(
W−2∑
r=0
λrp
(r)
j,k
)
g(k, 0)
+λW−1
N−1∑
k=0
p
(W−1)
j,k J(k)
)}
,
(5.12)
the optimal cost function satisfies
J∗(x) = lim
j′−→∞
(
TMJ
)
(x), ∀x ∈ S.
Proof
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We define g˜(i, u) as
g˜(i, u) = g(i, u) + λ
N−1∑
j=0
pi,j(u)
(
N−1∑
k=0
(
W−2∑
r=0
λrp
(r)
j,k
)
g(k, 0)
)
. (5.13)
The function g˜(i, u) collects the average cost of state i with control u and the accumulated
cost of W transitions from state i. For every positive integer K, initial state x0 ∈ S, and
policy pi = {µ0, µ1, . . . }, we break down the cost Jpi(x0) into the portions incurred over
the first K stages and over the remaining stages
Jpi(x0) = lim
M−→∞
E
{
M−1∑
k=0
λkW g˜(xk, µk(xk))
}
= E
{
K−1∑
k=0
λkW g˜(xk, µk(xk))
}
+ lim
M−→∞
E
{
M−1∑
k=K
λkW g˜(xk, µk(xk))
}
.
Since the cost-per-stage is bounded, it is straightforward to see that g˜(i, u) in (5.13) is
bounded. Let us assume |g˜(i, u)| < L. We also obtain
∣∣∣∣∣ limM−→∞E
{
M−1∑
k=K
λkW g˜(xk, µk(xk))
}∣∣∣∣∣ ≤ L
∞∑
k=K
λkW =
λWK
1− λW
L.
It follows that
Jpi(x0) ≤ E
{
K−1∑
k=0
λkW g˜(xk, µk(xk))
}
+
λWK
1− λW
L.
From the inequalities above, one can conclude that
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E
{
K−1∑
k=0
λkW g˜(xk, µk(xk)) + λ
WKJ(xK)
}
≥ E
{∣∣∣∣∣
K−1∑
k=0
λkW g˜(xk, µk(xk))
∣∣∣∣∣− ∣∣λWKJ(xK)∣∣
}
≥ Jpi(x0)−
λWK
1− λW
L− λWK max
x∈S
|J(x)|.
Similarly,
E
{
K−1∑
k=0
λkW g˜(xk, µk(xk)) + λ
WKJ(xK)
}
≤ E
{∣∣∣∣∣
K−1∑
k=0
λkW g˜(xk, µk(xk))
∣∣∣∣∣+ ∣∣λWKJ(xK)∣∣
}
≤ Jpi(x0) +
λWK
1− λW
L+ λWK max
x∈S
|J(x)|.
Hence,
Jpi(x0)−
λWK
1− λW
L− λWK max
x∈S
|J(x)|
≤ E
{
K−1∑
k=0
λkW g˜(xk, µk(xk)) + λ
WKJ(xK)
}
≤ Jpi(x0) +
λWK
1− λW
L+ λWK max
x∈S
|J(x)|.
We need to show thatE
{∑K−1
k=0 λ
kW g˜(xk, µk(xk)) + λ
WKJ(xK)
}
is equal to (TKJ)(x0).
From the definition of g˜(i, u) in (5.13) and (5.12), we have
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TJ(i) = min
u∈U(i)
{
g˜(i, u) + λW
N−1∑
j=0
pi,j(u)
(
N−1∑
k=0
p
(W−1)
j,k J(k)
)}
= min
u∈U(i)
{
g˜(i, u) + λW
N−1∑
k=0
(
N−1∑
j=0
pi,j(u)p
(W−1)
j,k J(k)
)}
.
We denote
∑N−1
k=0
∑N−1
j=0 pi,j(µ)p
(W−1)
j,k by
∑N−1
k=0 p
(W )
i,k (µ). When optimal policy µk(xk) is
applied, the above equation changes to
TµkJ(xk) = g˜(xk, µk(xk)) + λ
W
N−1∑
xk+1=0
p(W )xk,xk+1(µk(xk))J(xk+1).
Further application of Tµk+1 leads us to
Tµk+1TµkJ(xk) = g˜(xk, µk(xk)) + λ
W
N−1∑
xk+1=0
p(W )xk,xk+1(µk(xk))g˜(xk+1, µk+1(xk+1))
+ λ2W
N−1∑
xk+1=0
p(W )xk,xk+1(µk(xk))
N−1∑
xk+2=0
p(W )xk+1,xk+2(µk+1(xk+1))J(xk+2).
By induction, one can show that
TµKTµK−1 . . . J(x0) = E
{
K−1∑
k=0
λkW g˜(xk, µk(xk)) + λ
WKJ(xK)
}
.
By taking the minimization over pi, we obtain
J∗(x0)−
λWK
1− λW
L− λWK max
x∈S
|J(x)|
≤ (TKJ)(x0)
≤ J∗(x0) +
λWK
1− λW
L+ λWK max
x∈S
|J(x)|,
for all x0 and K. By taking the limit as K →∞, the result follows. 
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Propositions 2, 3 (in Chapter II), and 6 provide the basis for computational algorithms
to determine an optimal W-transition policy. Proposition 2 asserts that the optimal cost
function satisfies Bellman’s optimality equation, while Proposition 6 states that the optimal
cost function can be iteratively determined by running the recursion
Js+1 = TJs, s = 0, 1, 2, . . . (5.14)
for any bounded initial cost function J0 : S 7→ ℜ. An optimal W-transition policy is found
when the iteration converges to the optimal value of the cost function.
B. Results and Discussion
An optimal one-transition policy is no longer optimal, i.e. does not necessarily minimize
the expected total discounted cost, if one is restricted to apply treatment only every W tran-
sitions. Nevertheless, we can apply an optimal one-transition policy every W transitions
and compare the effect and cost of such a policy to the ones of an optimal W-transition
policy, which truly minimizes the expected total discounted cost.
We anticipate an effective control policy to reduce the likelihood of visiting undesir-
able states compared to a network without intervention by modifying the long-run behavior
of the network. The effectiveness of a control policy can be measured by the amount of
change (shift) in the aggregated probability of undesirable states before and after interven-
tion. We should emphasize that an optimal policy does not necessarily result in a max-
imum shift in the steady-state distribution, as explained above, since we are minimizing
the expected total discounted cost. The amount of shift in the aggregated probability of
undesirable states before and after intervention can be computed as
∆PW =
∑
i∈U pii −
∑
i∈U p˜i
W
i∑
i∈U pii
. (5.15)
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In (5.15), p˜iWi is the probability of being in undesirable state i in the long run using a
policy that is applied every W transitions. In this equation, pii is the probability of being
in undesirable state i in the long run when there is no intervention. In other words, given a
Markovian gene regulatory network, one can shift the aggregated probability of undesirable
states to desirable ones through appropriately altering the expression of the control gene
every W time instants.
Formulation of ∆PW requires the computation of p˜iW , i.e. the steady-state distribu-
tion of the Markov chain under a W-transition policy µW , a policy that is applied every W
transitions. To this end, we derive the transition probability matrix of the system when a
W-transition policy µW is applied. In general, W possible cases can happen for the tran-
sition of state i to state j in W steps under a cyclic policy depending on the instants in
which states i and j are observed with respect to the treatment times. Let us denote the
transition probability matrix under the W-transition policy µW by PµW . In the first case,
there are W − 1 uncontrolled transitions and the corresponding transition probability ma-
trix is PW−1. Afterward, in W th transition, policy µW decides whether to apply control
or not. The system transitions to state j and the corresponding transition probability ma-
trix is PµW . Consequently, the transition probability matrix corresponding to the first case
is P(W−1)PµW . In the second case, starting from state i, there are W − 2 uncontrolled
transitions and the corresponding transition probability matrix is PW−2. At next transition,
policy µW decides whether to apply control or not and the system transitions according
to the transition probability matrix PµW . Thereafter, the system transitions to state j ac-
cording to the original transition probability matrix P. The transition probability matrix
corresponding to the second case is P(W−2)PµW P. Likewise, the transition probability
matrix for W − 2 other cases can be derived. Fig. 11 demonstrates an example for W = 4.
As this figure suggests, 4 possible cases can happen depending on when state i is observed
with respect to treatment times.
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(a) (b)
(c) (d)
Fig. 11. An example of cyclic intervention strategy for W = 4. Arrows represent treatment
times. Subfigures a to d show the four possible cases that can happen depending on
the instants in which states i and j are observed with respect to treatment times.
To find the transition probability matrix of the Markov chain under optimal W-transition
policy, one should consider the possibility of these cases. Since each of these cases are
equally probable, the following transition probability matrix represents the probabilities of
transitions among states when the W-transition intervention policy µW is applied
PˆµW =
1
W
W∑
w=1
P(W−w)PµW P
(w−1). (5.16)
The steady-state distribution p˜iW is the invariant distribution of PˆµW .
In the following sections, we first derive optimal one-transition and W-transition poli-
cies for synthetic networks. We generate random PBNs with various properties. We vary
the values of bias and connectivity of the PBNs. The bias of a PBN is the probability that
each constituent Boolean function takes on the value 1 and the connectivity corresponds
to the maximum number of predictors for each Boolean function. Since the bias and con-
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nectivity affect the dynamical properties of randomly generated BNs [4], we take them as
parameters in our simulations. Whenever not specified, the connectivity of the PBN is 3.
Furthermore, we investigate the effect of the cost of control on each type of policy. We
provide some of these in the sequel. We then present a similar investigation for the network
obtained from the mammalian cell-cycle network explained in Chapter II.
1. Synthetic Networks
We generate random PBNs with 7 genes. Each PBN consists of 4 constituent BNs. For each
PBN, the probability transition matrix of the corresponding Markov chain is computed [5].
Without loss of generality, the target gene is chosen to be the most significant gene in the
states. We assume that the up-regulation of the target gene is undesirable. Consequently,
the state space is partitioned into desirable states, D = {0, . . . , N/2− 1}, and undesirable
states, U = {N/2, . . . , N − 1}, where N represents the total number of states. Since our
objective is to down-regulate the target gene, a higher cost is assigned to destination states
having an up-regulated target gene. We postulate the following cost-per-stage:
g(u, j) =

0 if u = 0 and j ∈ D,
5 if u = 0 and j ∈ U ,
c if u = 1 and j ∈ D,
5 + c if u = 1 and j ∈ U ,
(5.17)
where c represents the cost of control. Whenever it is not specified, the cost of control is
selected to be zero.
For each PBN, we vary the value of W from 1 to 10. For each W , the optimal W-
transition policy is derived and the corresponding ∆PW is computed from (5.16). Given
the optimal W-transition policy, we estimate the average total discounted cost induced by
this policy. To this end, we generate synthetic time-course data for 1000 time-steps from
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each PBN model while the optimal W-transition policy is applied. Using this synthetic
time-course data, we estimate the discounted cost by accumulating the discounted cost of
each state given the policy at that state. This procedure is repeated 10, 000 times for random
initial states and the average of the induced discounted cost is computed. Furthermore, the
optimal one-transition policy is applied every W transitions and the corresponding ∆PW
is computed from (5.16). To compute the average discounted cost of the optimal one-
transition policy when it is applied every W transitions, we generate synthetic time-course
data as explained above and the average total discounted cost of the optimal one-transition
policy is similarly computed. In summary, for each PBN model, we have the following:
(C¯W ) average total discounted cost resulting from the optimal W-transition policy; (∆PW )
the value of ∆PW resulting from the optimal W-transition policy; (C¯W,1) the average total
discounted cost of the optimal one-transition policy when it is applied every W transitions;
and (∆PW,1) the value of ∆PW resulting from the optimal one-transition policy applied
every W transitions. The preceding procedure is repeated for 1000 random PBNs, thereby
yielding 1000 values for each statistic: C¯W1 , . . . , C¯W1000;∆PW1 , . . . ,∆PW1000;C¯
W,1
1 , . . . , C¯
W,1
1000;
∆PW,11 , . . . ,∆P
W,1
1000. Using these, we compare the optimal W-transition and one-transition
polices via the empirical averages M[CW ] of C¯W1 , . . . , C¯W1000; M[CW,1] of C¯
W,1
1 , . . . , C¯
W,1
1000;
M[∆PW ] of ∆PW1 , . . . ,∆PW1000; and M[∆PW,1] of ∆P
W,1
1 , . . . ,∆P
W,1
1000. In addition, for
each value of W , the histograms of the differences C¯W,1i − C¯Wi and ∆PWi − ∆P
W,1
i ,
i = 1, . . . , 1000, are also found. We will see that the means tend to be close, M[CW ] ≈
M[CW,1] and M[∆PW ] ≈ M[∆PW,1], but that the histograms of the differences have long
tails to the right, indicating that there are cases for which using the optimal one-transition
policy can have strongly detrimental effects.
In the first set of experiments, each constituent BN is randomly generated with a bias,
the bias being the probability that a Boolean function takes on the value 1. We randomly
select the bias b of a BN from a beta distribution. The mean of the beta distribution is
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Fig. 12. Comparison of optimal W-transition and one-transition policies based on the av-
erage values of ∆PW and average total discounted cost for W ∈ {1, . . . , 10} for
random PBNs with bias mean = 0.3. (a) Average of discounted cost, (b) Average of
∆PW
chosen to be 0.3, 0.5, or 0.7. The variance of the beta distribution, σ2, is set to a constant
value 0.0001. The average values of ∆PW and the average total discounted costs for both
one-transition and W-transition policies are shown in Figs. 12 and 13 for bias values of 0.3
and 0.5, respectively. Similarly, the histograms of the differences of the two policies in
terms of ∆PW and the average total discounted costs are shown in Figs. 14 and 15.
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Fig. 13. Comparison of optimal W-transition and one-transition policies based on the av-
erage values of ∆PW and average total discounted cost for W ∈ {1, . . . , 10} for
random PBNs with bias mean = 0.5. (a) Average of discounted cost, (b) Average of
∆PW
We observe that the average of ∆PW for both policies decreases as W increases. This
behavior is in accordance with the intuition that treatments which are further apart in time
are less effective. As we stated in the Introduction, tumors given less time to grow between
treatments are more likely to be eradicated [14]. In the long run, less treatment is applied
for a larger W and consequently more cost is induced. Hence, for a fixed bias, the average
discounted costs of both one-transition and W-transition policies increase as W increases.
On average, the optimal W-transition policy results in lower discounted cost and higher
∆PW compared to the optimal one-transition policy. The histograms of the differences of
the two policies in terms of ∆PW and average discounted show how often they generate
similar outcomes and how often the effect of the two policies differ. Note that the dif-
ferences are not positive for all PBNs. This is because the optimal policies minimize the
‘expected’ total discounted cost. Hence, the W-transition control policy can induce a larger
average discounted cost compared to the one-transition control policy, but rarely.
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In the second set of experiments, we generate constituent BNs with connectivities 2,
3, and 4. For each connectivity, predictors and Boolean functions are randomly generated
with a bias b, randomly selected from a beta distribution with mean 0.5. Similar to the
previous experiment, we observe that the optimal W-transition policy results in lower aver-
age discounted cost and higher ∆PW compared to the optimal one-transition policy. In the
third set of experiments, we repeat the simulations for the cost of control being 0, 0.1, and
0.5. Results of this experiment for control cost of 0.1 are shown in Figs. 16 and 17.
2. Mammalian Cell-Cycle Network
The value of ∆PW and the average total discounted cost for both optimal one-transition and
W-transition policies derived for the cell-cycle network are shown in Fig. 18. In the long
run, less treatment is applied for a larger W and consequently more cost is induced. Hence,
the average discounted costs of both optimal one-transition and W-transition policies in-
crease as W increases. It should be noted that the previous experiments show the average
behavior of 1000 random PBNs while this experiment considers the behavior of one net-
work, i.e. the mammalian cell-cycle network. In this instance, the optimal one-transition
and W-transition policies are close to parity for the cell-cycle network.
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Fig. 14. Comparison of optimal W-transition and one-transition policies based on the his-
togram of difference of W-transition and optimal one-transition policies for W = 5
on random PBNs with bias mean = 0.3. (a) Histogram of ∆PW associated to op-
timal W-transition policy minus ∆PW associated to optimal one-transition policy,
(b) Histogram of the average discounted cost associated to optimal one-transition
policy minus the average discounted cost associated to optimal W-transition policy,
(c) enlarged view of (a), (d) enlarged view of (b)
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Fig. 15. Comparison of optimal W-transition and one-transition policies based on the his-
togram of difference of W-transition and optimal one-transition policies for W = 5
on random PBNs with bias mean = 0.5. (a) Histogram of ∆PW associated to op-
timal W-transition policy minus ∆PW associated to optimal one-transition policy,
(b) Histogram of the average discounted cost associated to optimal one-transition
policy minus the average discounted cost associated to optimal W-transition policy,
(c) enlarged view of (a), (d) enlarged view of (b)
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Fig. 16. Comparison of optimal W-transition and one-transition policies based on the av-
erage values of ∆PW and average total discounted cost for W ∈ {1, . . . , 10} for
random PBNs with control cost = 0.1. (a) Average of ∆PW , (b) Average of dis-
counted cost.
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Fig. 17. Comparison of optimal W-transition and one-transition policies based on the his-
togram of difference of optimal W-transition and one-transition policies for W = 5
on random PBNs when cost of control is 0.1. (a) Histogram of ∆PW associated to
optimal W-transition policy minus ∆PW associated to optimal one-transition pol-
icy, (b) Histogram of the average discounted cost associated to optimal one-tran-
sition policy minus the average discounted cost associated to optimal W-transition
policy, (c) enlarged view of (a), (d) enlarged view of (b)
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Fig. 18. Comparison of optimal W-transition and one-transition policies based on the values
of ∆PW and average total discounted cost for W ∈ {1, . . . , 10} for the mammalian
cell-cycle network. (a) Average of total discounted cost, (b) ∆PW
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CHAPTER VI
MEAN-FIRST-PASSAGE-TIME CONTROL POLICY∗
The study of infinite-horizon intervention strategies poses two fundamental questions. First,
is it possible to beneficially affect a network by applying the optimal stationary control pol-
icy? This translates into assessing the controllability of the network. In practice, a physi-
cian would like to predict the effectiveness of a certain treatment at different stages of a
disease and on different patients. Investigating the effect of a certain type of control on
various networks is equivalent to questioning the controllability of the network. To date,
there has been no investigation on this important topic in the context of gene regulatory net-
works. Second, can we identify the best intervening gene? In other words, which gene is
the best potential “lever point,” to borrow the terminology from [32], in the sense of having
the greatest possible impact on the desired network behavior? In principle, solving an opti-
mal control problem for each candidate gene and comparing the performance of the system
for these various controls would answer these questions; however, this process is a compu-
tationally demanding procedure. The complexity of dynamic programming algorithms can
be vast and increases exponentially with the number of genes [40].
In their early papers, Shmulevich et al. employ two methods for selecting a candidate
gene for intervention: mean first-passage time and influence [5, 6]. The following biolog-
ical example, borrowed from [4], explains the intuition behind using mean first-passage
times for selecting the best control gene. In biology, there are numerous cases where the
(in)activation of a certain gene or protein can lead more quickly (or with higher probability)
to a particular cellular functional state or phenotype than the (in)activation of another gene
∗ Reprinted with permission from “ Intervention in Gene Regulatory Networks via a
Stationary Mean-First-Passage-Time Control Policy” by G. Vahedi, B. Faryabi, J.-F. Cham-
berland, A. Datta, and E. R. Dougherty, 2008, IEEE Transactions on Biomedical Engineer-
ing, 55, 2319-2331, Copyright 2008 by IEEE.
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or protein. For instance, in a stable cancer cell line, in the absence of intervention, the cells
will keep proliferating. This behavior can be reversed by controlling the expression of cer-
tain genes. Assume that the goal of the intervention is to push the cell into programmed cell
death (apoptosis). Further assume that we can achieve this intervention with two candidate
genes: p53 and telomerase. The p53 gene is the most well-known tumor suppressor gene
[41][42][43]. The telomerase gene encodes telomerase, which maintains the integrity of the
end of chromosomes (telomeres) in germ cells. Germ cells are responsible for propagating
the complete genetic material to the following generation. Telomerase also maintains the
integrity of the end of chromosomes in progenitor cells. Progenitor cells are responsible
for replenishing cells during the normal cell turnover (homeostasis). In somatic cells, the
telomerase gene is turned off, resulting in telomere shortening each time the cell divides –
a key reason for the limited life-span of normal cells [44]. In the majority of tumor cells,
telomerase is activated, which is believed to contribute to the prolonged life-span of the
tumor cells [45]. This worsens prognosis for cancer patients [46][47]. Extensive experi-
mental results indicate that when p53 is activated in the cells, for example in response to
radiation, the cells undergo rapid growth inhibition and apoptosis in as short as a few hours
[48]. In contrast, inhibition of the telomerase gene also leads to cell growth inhibition,
differentiation, and cell death, but only after cells go through a number of cell divisions
(allowing telomere shortening). Cell death takes a longer time through this latter process
than via p53 activation. The use of mean first-passage times for finding the best control
gene is intuitive; however, it focuses on a one-step control scenario.
The influence method distinguishes genes that have a major impact on a predictor
function from those that have only a minor impact. This method was introduced to reflect
the extent to which a set of genes is capable of determining the value of a target gene [5].
It has been used as a criterion to select a control gene with the suggestion that the gene
with the largest influence on the target gene is likely to be a good control gene in the finite
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and infinite-horizon control of PBNs [49][11]; however, no research has been done on the
overall performance of this heuristic measure.
Capitalizing on the biological intuition behind mean first-passage time, we propose an
algorithm based on mean first-passage times that assigns a stationary control policy for each
candidate gene. We call this algorithm the Mean First-Passage Time (MFPT) algorithm
and refer to the corresponding stationary control policy as the Mean First-Passage Time
(MFPT) control policy. The proposed algorithm selects the MFPT control policy based
on two heuristics: (1) it is preferable to reach desirable states as early as possible; (2) it
is preferable to leave undesirable states as early as possible. The MFPT algorithm can be
employed in four main applications.
First, the MFPT algorithm can be used for predicting the best control gene. The MFPT
algorithm enables the computation of the MFPT control policies for all the genes in the net-
work with a manageable complexity. The control gene with the highest desirable effect on
the long-run behavior of the network upon the application of the corresponding MFPT con-
trol policy is likely the most effective gene for controlling the biological system. Second, to
reduce the complexity of the optimal stochastic control problem, the MFPT control policy
can be used as an approximate solution. Contrary to optimal algorithms, the MFPT algo-
rithm finds policies with constant complexity. Third, the MFPT algorithm can be used to
measure the controllability of a network. Since the MFPT control policy is an approxima-
tion for the optimal control policy, one can define a network to be controllable if the effect
of the MFPT control policy is greater than a desired threshold.
Finally, the MFPT algorithm can be used to design a control policy without requiring
network inference. The optimal stochastic control polices proposed thus far require perfect
knowledge of the probability transition matrix governing the network, which must be de-
rived from the PBN or inferred directly. These procedures are prone to modeling errors and
suffer from problems of computational complexity for both network inference and finding
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the optimal control solutions. To achieve model-free intervention, the MFPT control policy
can be designed based on estimates of the mean first-passage times. The model-free inter-
vention method has low complexity, is robust to modeling errors, and adapts to changes in
the underlying biological system.
A. Mean-First-Passage-Time Algorithm
In this section, we first elaborate on how the MFPT algorithm is designed based on the
mean first-passage time. We then summarize the MFPT algorithm. Application of the
MFPT algorithm requires the designation of desirable and undesirable states, and this de-
pends upon the existence of relevant biological knowledge. Intervention is performed by
flipping (toggling) the expression status of a particular gene from ON to OFF or vice-versa,
the intent being to externally guide the time evolution of the network towards more de-
sirable states. If g is the control gene, then applying the control (intervention) in state x
translates into flipping the value of g in that state (the control gene g changes to 0 if its value
is 1 and vice-versa). Consequently, the network resumes its transition from the new state
x˜, which we call the flipped-state. In the context of therapy, the state-space of a PBN can
be partitioned into desirable and undesirable states. Given a control gene, when a desirable
state reaches the set of undesirable states on average faster than its flipped-state, it is rea-
sonable to intervene and transition into the flipped-state. Similarly, if an undesirable state
reaches the set of desirable states on average faster than its flipped-state, it is reasonable
not to intervene. These insights motivate the use of mean first-passage times for designing
intervention strategies.
Without loss of generality we can assume that the transition probability matrix P of
the Markov chain (representing a PBN) is partitioned according to
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P =
(
PD,D PD,U
PU ,D PU ,U
)
,
where D and U are the subsets of desirable and undesirable states, respectively. The mean
first-passage times are computed by solving the following systems of linear equations [19]:
KU = e+ PD,D ·KU , (6.1)
KD = e+ PU ,U ·KD, (6.2)
where e is a column vector of 1’s with appropriate length, KU is a vector containing the
mean first-passage times from each state in the subset of desirable states D to undesirable
states in set U , and KD is a vector containing the mean first-passage times from each state
in the subset of undesirable states U to the desirable states in set D.
A control policy µg corresponding to control gene g is a vector of size 2n, the number
of states in the network. The decision rule µg : S → C specifies the control action for
each state x in S. Having µg(x) = 0 for state x means that, whenever the network reaches
state x, no control is applied and the system continues its transition based on the transition
probabilities of state x. On the other hand, having µg(x) = 1 implies that, whenever the
network reaches state x, the control is applied and the system continues its evolution based
on the transition probabilities of state x˜, the flipped-state of x.
The goal of the MFPT algorithm is to design the MFPT control policies {µˆg}ng=1.
The objective is to choose a control value u for every state in S such that the network
evolves towards more desirable states. The MFPT algorithm selects the control policy
for control gene g in the following manner. Assume state x is an undesirable state. We
compare the mean first-passage times from state x to D and from the flipped-state x˜ to D.
In other words, we would like to know on average which one of these two states, x and
x˜, hits the set of desirable states for the first time faster than the other one. The algorithm
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chooses µˆg(x) = 1 if the difference between the mean first-passage times of state x and the
flipped-state x˜ to the set of desirable states, i.e. KD(x) −KD(x˜), is greater than a tuning
parameter γ (to be discussed). Otherwise, µˆg(x) = 0. Analogously, if state x is desirable,
then µˆg(x) = 1 if the difference between the mean first-passage times of state x and the
flipped-state x˜ to undesirable states, i.e. KU(x˜) − KU(x), is greater than γ. Otherwise,
µˆg(x) = 0. These comparisons are repeated for all states. Algorithm 1 summarizes the
proposed procedure.
The threshold γ in the MFPT algorithm is a tuning parameter chosen based on the ratio
of the cost of control to the cost of undesirable states. When the cost of applying treatment
in a state is high compared to the cost of undesirable states, an optimal control policy is
less likely to apply the control frequently. Thus, γ is set to a larger value when this ratio
is higher, the intent being to apply control less frequently. We explain after the following
definitions how one can set this parameter.
An effective control policy reduces the likelihood of visiting undesirable states com-
pared to a network without intervention by modifying the long-run behavior of the network.
The effectiveness of a control policy can be measured by the amount of change (shift) in
the aggregated probability of undesirable states before and after intervention. As a perfor-
mance measure we define
∆Pg =
∑
i∈U pii −
∑
i∈U pi
g
i∑
i∈U pii
,
where pigi is the probability of being in undesirable state i in the long-run after intervening
with control gene g, and pii is the probability of being in undesirable state i in the long-run
when there is no intervention. The ratio ∆Pg measures the proportion of reduction in the
total probability of undesirable states in the steady state when the control gene g is selected.
We denote this proportion by ∆P optg when an optimal control policy µ∗g is applied. In other
words, in the optimal case one can shift the aggregated probability of undesirable states to
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Algorithm 1 MFPT algorithm
Partition the state-space into undesirable U and desirable D subsets.
Compute KU and KD.
g ← 1.
repeat
for All states x in U do
x˜ ← flip control gene g in x.
if KD(x)−KD(x˜) > γ then
µg(x) = 1;
else
µg(x) = 0;
end if
end for
for All states x in D do
x˜ ← flip control gene g in x.
if KU(x˜)−KU(x) > γ then
µg(x) = 1;
else
µg(x) = 0;
end if
end for
g ← g + 1.
until g > number of genes
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desirable states by ∆P optg through appropriately altering the expression of the control gene
g. Similarly, the shift obtained by the MFPT control policy µˆγg is denoted by ∆P
MFPT(γ)
g ,
where γ is the tuning parameter.
We define the probability of the execution of control as
Γg =
2n−1∑
j=0
pij · 1(µg(j) = 1), (6.3)
where n is the number of genes, pij is the steady-state probability of state j ∈ S, µg(j) is
the value of the control policy in state j, and 1(·) is the indicator function. The purpose
of introducing this probability is to have a fair evaluation of the performance of the MFPT
control policy in terms of the number of control executions, which for the optimal policy
is related to the cost of control. For each control gene g, one can define Γoptg as the prob-
ability of the execution of control when the optimal control policy is applied. Similarly,
Γ
MFPT(γ)
g is the probability of the execution of control when the MFPT control policy with
the parameter γ is applied.
We numerically find the value of the parameter γ for each control cost. We generate
random intervention problems and calculate the averages of Γoptg and Γ
MFPT(γ)
g . These av-
erages are taken over random intervention problems with fixed control cost. Starting from
γ = 0, we increase the value of γ. For each control cost, the desired value of γ is the mini-
mal one for which, on average, Γoptg > Γ
MFPT(γ)
g . This condition guarantees that on average
the MFPT control policy applies no more control than the optimal control policy. Since the
values of the parameter γ are found from random intervention problems, in practice one can
have a conservative approach and choose the parameter γ to be greater than the proposed
value. The conservative approach can assure a high probability that Γoptg > Γ
MFPT(γ)
g . On
the other hand, the deviation of ∆PMFPT(γ)g from ∆P optg becomes larger.
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B. Applications of the MFPT Algorithm
We devise solutions according to the MFPT algorithm for four intervention applications.
1. Identification of the Best Control Gene
Recalling the example of p53 and telomerase in the introduction, it is important to select
the most effective control gene in a therapeutical intervention. The best control gene g∗ can
be found by directly solving a dynamic programming algorithm and computing {∆P optg }ng=1
for all the genes g in the network. In short, g∗ is given by
g∗ = arg max
g=1...n
∆P optg ; (6.4)
however, this optimal method to find the best control gene is computationally prohibitive.
On the other hand, the MFPT algorithm enables the computation of the MFPT control
policies {µˆγg}ng=1 for all the genes in the network with an acceptable complexity. Taking
this approach, the MFPT algorithm predicts the best control gene to be
gˆ = arg max
g=1...n
∆PMFPT(γ)g . (6.5)
We will show that gˆ = g∗ with high probability, and that ∆P optg∗ − ∆P
opt
gˆ is small
whenever gˆ 6= g∗. In this context, we are using the MFPT algorithm to find the control gene.
Once the best gene candidate is identified, an optimal control policy can be obtained using
dynamic programming algorithms. We will also show that the MFPT-based prediction of
the best control gene significantly outperforms the influence method.
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2. Approximation of the Optimal Control Policy
The MFPT algorithm can devise an intervention strategy as an approximation of the optimal
intervention strategy. To this end, we numerically find the value of the parameter γ for each
control cost so that, on average, Γoptg∗ > ΓMFPTg∗ . To assess the accuracy of the approximation,
we show that the average of ∆P optg∗ − ∆P
MFPT(γ)
g∗ over random intervention problems with
fixed control cost is small. Note that, so as not to confound approximation accuracy with
the MFPT algorithm’s ability to find a control gene, we apply both the optimal and MFPT
methods using the optimal control gene g∗.
3. Controllability
An important aspect of prognosis is quantifying the possibility of recovery. In our frame-
work, this amounts to quantifying the controllability of a gene regulatory network, a con-
cept borrowed from traditional control theory. Can the network be sufficiently controlled
to provide meaningful recovery? We desire a controllability measure where the objective
of the control is to reduce the likelihood of observing the undesirable states in the long-run.
An optimal control strategy takes into account the cost of control, but here we want only
to focus on the possibility of sufficient control, absent concerns with costs, either medical
or financial. To this end, we choose the cost of control to be zero. The zero control-cost
strategy admits any number of states with active control. Our point (one that is certainly
debatable) is that we desire a measure of controllability with no restrictions on the num-
ber of times the control might be applied. Thus, a possible approach is to set the cost
of control to zero and compute ∆P optg∗ . To reduce the computational burden, we propose
∆P
MFPT(0)
g∗ (γ = 0) as a controllability measure. Our simulations show that the ∆PMFPT(0)g∗
is a highly accurate approximation of ∆P optg∗ when the cost of control is zero. Therefore,
the MFPT algorithm can be employed to determine the controllability of a network. For
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example if ∆PMFPT(0)g∗ is very small, we conclude that the network is not controllable. If
∆P
MFPT(0)
g∗ = 0.5, then we conclude that it is possible to shift 50% of the probability mass
of the undesirable states to desirable ones in the long-run, given the application of the
control has zero cost.
4. Model-free Intervention
To date, the proposed intervention methods for PBNs are model dependent, requiring
knowledge of the transition probability matrix. This can be derived from the PBN if the
latter is known. Since in practice PBNs are not known except via system identification
from observed data, one is faced with a difficult inference problem [50]. This problem
can be avoided by directly inferring the transition probability matrix; however, this is still
a formidable task because the complexity of estimating the transition probabilities of a
Markov chain increases exponentially with the number of genes in the model. When time-
course data are available, the MFPT algorithm can be implemented by directly estimating
the mean first-passage times. The estimated mean first-passage times are used to construct
the matrices of the mean first-passage times, KU and KD. The MFPT algorithm can then be
applied to the estimated matrices KU and KD to devise a model-free MFPT control policy.
In the following, we propose a procedure for estimating the mean first-passage times
from time-course measurements. Assume x is a desirable state and it is observed at time t0.
Further assume that, starting from time t0, the first undesirable state occurs at time t0 + k0.
In other words, it takes k0 time points for the desirable state x to transition (reach) to an
undesirable state. Similarly, assume the next observation of state x is at time t1 and since
time t1 the first undesirable state occurs at time t1 + k1. In this example, the average first
passage time from state x to the subset of undesirable states is (k0 + k1)/2. Likewise, one
can define an example for an undesirable state y reaching the subset of desirable states. It
is evident that for larger numbers of observations, this estimation becomes more accurate.
88
The above procedure needs to be implemented with low complexity. At each time point,
we update the number of steps for each state to reach the opposite subset of states and store
the frequency of the occurrence of each state. One needs to update the average first passage
times for a new observation. The complexity of estimating the mean first-passage times
following our procedure is constant with respect to the number of genes for each iteration.
An advantage of the model-free approach is that the estimated matrices KU and KD
can be updated whenever new time-course data become available. The possibility of updat-
ing the estimated mean first-passage times enables the MFPT algorithm to adapt its control
policy to the status of gene interactions. In other words, the model-free MFPT control
method is adaptive to changes in the network model. In contrary, the control policy de-
vised by the existing intervention methods cannot adapt to the changes in the status of gene
interactions. Once the PBN is inferred form data, the model-dependent control policy is
fixed.
Through numerical studies, we will exhibit the effectiveness of the model-free MFPT
control policy obtained by estimating the mean first-passage times. On one hand, we will
estimate the matricesKU andKD based on synthetic time-course data and use the MFPT al-
gorithm to find the control policy; on the other hand, we will use the same time-course data
to build a Markov chain representing the dynamics of the model and then find the control
policy based on the estimated transition probability matrix using dynamic programming.
We will observe that the MFPT control policy based on the estimated mean first-passage
times outperforms the control policy devised from the estimated transition probabilities of
the Markov chain, given the same set of time-course data, for feasible size data sets.
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C. Complexity Analysis of the MFPT Algorithm
The main objective of an effective intervention strategy is to reduce the likelihood of visit-
ing undesirable states compared to a network without intervention by modifying the long-
run behavior of the network. Given a time-course data set, there are two possible ap-
proaches for designing a strategy for any model such that its dynamic behavior can be
represented as a Markov chain (such as PBN or Dynamic Bayesian Network).
In the first approach, one can estimate the transition probabilities of the states from
time-course measurements. Let us call this approach model-dependent. We require all the
details about the model, i.e. the transition probabilities of the Markov chain. Various meth-
ods can be employed to design an effective intervention strategy based on the estimated
model. The optimal control policy can be designed via dynamic programming techniques
[11]. In favor of lower computational complexity, an approximation of the optimal control
policy can be achieved using the MFPT algorithm.
In the second approach, an effective intervention strategy can be designed directly
from time-course measurements. We call this approach model-free. In contrary to the
model-dependent approach where the transition probabilities of the Markov chain are needed,
we do not require the details of the model. To this end, a model-free algorithm based on
reinforcement learning has recently been introduced [39]. This method bypasses the im-
pediment of model estimation and an effective control policy can be designed with a low
complexity. We propose that the MFPT algorithm can also be considered as a model-free
method. In this section, we analyze the complexity of the model-based and the model-free
MFPT algorithms.
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1. Model-dependent Approach
In the previous section, we introduced the four major applications of the MFPT algorithm:
identification of the best control gene, approximation of an optimal control policy, con-
trollability, and model-free intervention. Employment of the MFPT algorithm in the first
three applications is considered as a model-dependent approach since it is assumed that the
transition probability matrix of the Markov chain is known. Given the model is known, let
us compare the computational complexities of the dynamic programming and the MFPT
algorithms.
To find an optimal control policy using value or policy iteration, one should iteratively
find the value (cost) function until the algorithm reaches the fixed point of the Bellman
optimality equation. Once the optimal cost functions are computed, one must check which
control value attains the minimum in the right-hand side of the Bellman optimality equa-
tion and this procedure should be iterated for all the states. To the best of our knowledge,
there does not exist a tight upper bound on the number of iterations required to find an
optimal policy using either value or policy iteration, despite recent research initiatives [51].
Given the control gene, the policy iteration algorithm has complexity O(23n) per iteration,
whereas the complete complexity of the MFPT algorithm, which consists of two matrix
inversions, is O(23n). In general, it is known that the policy iteration algorithm converges,
but it is not known whether “the number of iterations in policy iteration can be bounded by
a polynomial in the instance size” [51]. Even assuming that the number of iterations can be
bounded by a polynomial in the number of states, the complexity of the MFPT algorithm
is lower than the policy iteration algorithm because it is computed once and does not re-
quire iteration. Regarding the value iteration algorithm, the asymptotic upper bound on the
number of iterations required to find an optimal policy using the value iteration algorithm
is polynomial in the number of states [51]. The degree of the polynomial is determined
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to be greater than two in special cases [52, 53]. Given the complexity of each iteration in
the value iteration algorithm is O(22n), the complexity of the value iteration algorithm to
find an optimal control policy is O(2(2+α)n), where α > 1. Hence, the complexity of the
MFPT algorithm is also lower than the complexity of the value iteration algorithm. To find
the optimal cost functions for n control genes, the complexity of a dynamic programming
algorithm is n times the complexity of this algorithm for one control gene. In contrary,
once the mean first-passage time vectors are computed, they can be used to devise MFPT
control policies for all control genes.
It is important to point out that for any control gene, in addition to the above complex-
ities, the dynamic programming and the MFPT algorithms must loop over all the states to
find their corresponding control policies. In dynamic programming algorithms, to obtain
the optimal control policy, one must check which control value attains the minimum in the
right-hand side of the Bellman optimality equation and this procedure must be iterated for
all the states. In the MFPT algorithm, one must investigate which control value leads to
a more favorable mean first-passage time and this procedure must be repeated for all the
states.
It is evident from the above analysis that the application of our proposed method is
restricted to small number of genes since the complexity of the MFPT algorithm increases
exponentially with the number of genes. We should point out that in our application of
interest, intervention in gene regulatory networks, the goal is not to model fine-grained
molecular interactions among a host of genes, but rather to model a limited number of
genes, typically with very coarse quantization, whose regulatory activities are significantly
related to a particular aspect of a specific disease, such as metastasis in melanoma [8].
Hence, while the asymptotic results on the complexities of optimal algorithms are encour-
aging, they are not our main interest; rather our problem deals with networks with small
numbers of states. Fig. 19 shows the average execution time of the value and policy iter-
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ation algorithms over 1000 randomly generated intervention problems as a function of the
number of genes n, along with the execution times of the MFPT algorithm. Per this figure,
the execution time of the MFPT algorithm is much smaller than the execution time of the
two optimal algorithms. The direct comparison has been limited to 10-gene networks on
account of the high complexity of the modeling and optimal intervention algorithms. The
maximum size of the intervention problem which can be solved by our MFPT method is
hardware-dependent. For instance, our current hardware configuration (single Xeon pro-
cessor and 1-GB memory) can obtain MFPT intervention policy for a synthetic 15-gene
regulatory network, which, given the data limits of current expression measuring technol-
ogy, is sufficient for the applications in which we are now engaged. Given more memory
and processing power, intervention strategies can be designed for larger networks. Should
the need arise for larger networks, we will consider implementation on our Beowulf cluster
at the Translational Genomics Research Institute.
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Fig. 19. The average execution time of the value and policy iteration algorithms over 1000
randomly generated intervention problems as functions of the number of genes,
along with the execution times of the MFPT algorithm.
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2. Model-free Approach
The model-dependent approaches yield effective solutions for large numbers of observa-
tions. However, these approaches have major drawbacks in practice. For lower numbers of
observations, which correspond better to feasible experimental conditions, estimating the
Markov chain yields poor results. Estimation errors may have a huge impact on finding
an effective intervention strategy, which is often quite sensitive to changes in the transition
probabilities [54]. Furthermore, the complexity of estimating the transition probabilities of
a Markov chain increases exponentially with the number of genes in the model, O(22n).
This is in addition to the complexity of designing an effective intervention strategy. Hence,
a procedure that can find an effective intervention strategy without having to know the
transition probabilities is very attractive.
The model-free based MFPT algorithm (fourth application) estimates the mean first-
passage times from time-course measurements. The complexity of estimating these vectors
following the proposed procedure in the previous section is constant with respect to n for
each iteration, where n denotes the number of genes. In other words, we devise an effective
intervention strategy by learning about the mean first-passage times directly from the data.
The highlight of this paper is the possibility of employing the MFPT algorithm in a
model-free approach. To this end, we summarize the two main benefits of our proposed
model-free method: 1) The complexity of the modeling and intervention is significantly
less than that of the model-dependent methods; 2) In contrary to the optimal control prob-
lem approach, which is sensitive to changes in the system, the MFPT algorithm needs the
average behavior of the system and is expected to be more appealing for smaller numbers of
observations. We corroborate this claim in the result section by comparing the model-free
MFPT method with the model-dependent optimal control method.
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D. Results and Discussion
In this section, we first study the performance of the MFPT algorithm for each of the afore-
mentioned applications through extensive simulations of random PBNs. We then compare
the performance of the MFPT algorithm and the influence method for the network obtained
from a melanoma gene-expression data set.
1. Synthetic Networks
We postulate the following cost-per-stage:
g(u, j) =

0 if u = 0 and j ∈ D,
10 if u = 0 and j ∈ U ,
c if u = 1 and j ∈ D,
10 + c if u = 1 and j ∈ U ,
where c is the cost of control. The target gene is chosen to be the most significant gene
in the GAP. We assume the up-regulation of the target gene is undesirable. Consequently,
the state-space is partitioned into desirable states, D = {0, . . . , 2n−1 − 1}, and undesirable
states, U = {2n−1, . . . , 2n − 1}, where n is the number of genes. The cost values have
been chosen in accord with an earlier study [11]. Since our objective is to down-regulate
the target gene, a higher cost is assigned to destination states having an up-regulated target
gene. Moreover, for a given status of the target gene for a destination state, a higher cost is
assigned when the control is applied, versus when it is not. In order to investigate the effect
of the cost of control in our algorithm, we vary its value from 0 to 10, which is the cost of
the undesirable states.
We generate random PBNs in the following manner. Each PBN consists of 10 con-
stituent BNs. Each BN is randomly generated with a specific bias b, the bias being the
probability that a randomly generated Boolean function takes on the value 1. Since the bias
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affects the dynamical properties of randomly generated BNs [4], we take it as a parameter
in our simulations. We randomly select the bias b of a BN from a beta distribution. We vary
the mean of the beta distribution from 0.3 to 0.7 with step-size 0.1. The variance σ2 of the
beta distribution is set to a constant value 0.0001. This provides random biases from low
(0.3) to high (0.7). We generate 1000 random PBNs for each bias mean. For each PBN,
the transition probabilities of the corresponding Markov chain are estimated. The above
procedure is repeated for networks of 5 to 10 genes. Due to the computational complexity
of the optimal stochastic control problem and the estimation of the transition probabilities
of the corresponding Markov chain, the study of a large number of networks beyond 10
genes is outside our current computational capacity.
a. Identification of the Best Control Gene
We first show the performance of the MFPT algorithm and the influence method when they
are employed to predict the best control gene. It is assumed that the cost of control c is equal
to 1. In Tables VIII, X, IX, and XI, we compare the performances of the MFPT algorithm
and the influence method for predicting the best control gene. First the optimal control
policy for each control gene is obtained by a dynamic programming algorithm. The best
control gene g∗ is found based on (6.4). Similarly, the MFPT control policy for each control
gene is computed and the predicted control gene gˆ is found based on (6.5). The influence
method is also employed to predict the best control gene. The predicted best control gene
by the influence method is denoted g˘. We define the probability of the correct prediction
of each method to be the number of PBNs for which the method correctly predicts the best
control gene divided by the total number of PBNs in the experiment. The probabilities of
correctly predicting the best control gene by the MFPT algorithm and the influence method
are shown in Tables VIII and X. The average differences between proportions of reduction
in the total probability of undesirable states corresponding to the gene predicted by each
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method and the best control gene, i.e. (∆P optg∗ −∆P optgˆ ) and (∆P optg∗ −∆P optg˘ ), are shown in
Tables IX and XI. In our experiments, the probability of the correct prediction by the MFPT
algorithm is always greater than 0.94. Table. IX shows that ∆P optg∗ − ∆P
opt
gˆ on average is
less than 0.0002.
Table VIII. The probability of finding the best control gene with the MFPT algorithm when
c = 1 for networks with different number of genes.
Bias 0.3 0.4 0.5 0.6 0.7
(A) 5 genes 0.9850 0.9640 0.9570 0.9600 0.9720
(B) 6 genes 0.9430 0.9700 0.9760 0.9580 0.9870
(C) 7 genes 0.9440 0.9680 0.9670 0.9700 0.9570
(D) 8 genes 0.9660 0.9740 0.9860 0.9790 0.9710
(E) 9 genes 0.9132 0.9233 0.9741 0.9812 0.9812
(F) 10 genes 0.9470 0.9570 0.9860 0.9690 0.9610
Table IX. The average difference between the proportions of reduction in the total proba-
bility of undesirable states obtained by the best control gene g∗ and the predicted
control gene obtained by the MFPT algorithm gˆ for networks with various number
of genes.
Bias 0.3 0.4 0.5 0.6 0.7
(A) 5 genes 0.0000 0.0000 0.0001 0.0001 0.0001
(B) 6 genes 0.00016 0.00010 0.00003 0.00006 0.00006
(C) 7 genes 0.00013 0.00013 0.00006 0.00005 0.00005
(D) 8 genes 0.0001 0.00008 0.00005 0.00002 0.00003
(E) 9 genes 0.0002 0.00001 0.00001 0.00004 0.00001
(F) 10 genes 0.0001 0.00008 0.00003 0.00002 0.00005
Table X. The probability of finding the best control gene with the influence method when c
= 1 for networks with different number of genes.
Bias 0.3 0.4 0.5 0.6 0.7
(A) 5 genes 0.6660 0.6240 0.5480 0.5670 0.5740
(B) 6 genes 0.5630 0.5320 0.4790 0.5070 0.5340
(C) 7 genes 0.5470 0.5550 0.5320 0.5460 0.5060
(D) 8 genes 0.5190 0.5290 0.5290 0.5780 0.5600
(E) 9 genes 0.5086 0.5186 0.5186 0.5676 0.5496
(F) 10 genes 0.5480 0.5230 0.5030 0.4010 0.4610
The performance of the influence method is also shown in Tables X and XI. These
tables suggest that approximately 0.60 of the time the influence method’s prediction is
correct. In general, ∆P optg∗ − ∆P
opt
g˘ is greater than 0.001. Tables XII, XIII, XIV, and XV
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Table XI. The average difference between the proportions of reduction in the total proba-
bility of undesirable states obtained by the best control gene g∗ and the predicted
control gene obtained by the influence method g˘ for networks with various num-
ber of genes.
Bias 0.3 0.4 0.5 0.6 0.7
(A) 5 genes 0.0079 0.0109 0.0102 0.0133 0.0134
(B) 6 genes 0.0081 0.0107 0.0140 0.0207 0.0158
(C) 7 genes 0.0086 0.0108 0.0104 0.0115 0.0130
(D) 8 genes 0.0100 0.0137 0.0151 0.0180 0.0131
(E) 9 genes 0.0016 0.0228 0.0134 0.0415 0.0130
(F) 10 genes 0.0104 0.0097 0.0152 0.0178 0.0211
Table XII. The probability of finding the best control gene with the MFPT algorithm.
Bias 0.3 0.4 0.5 0.6 0.7
(A) c=2 0.9034 0.9121 0.8983 0.8848 0.9085
(B) c=4 0.8614 0.8897 0.8839 0.8701 0.8035
Table XIII. The average difference between the proportions of reduction in the total proba-
bility of undesirable states obtained by the best control gene g∗ and the predicted
control gene obtained by the MFPT algorithm gˆ with various cost values.
Bias 0.3 0.4 0.5 0.6 0.7
(A) c=2 0.0004 0.0005 0.0006 0.0008 0.0005
(B) c=4 0.0020 0.0013 0.0014 0.0020 0.0022
Table XIV. The probability of finding the best control gene with the influence method.
Bias 0.3 0.4 0.5 0.6 0.7
(A) c=2 0.6432 0.6670 0.5950 0.5755 0.6050
(B) c=4 0.6151 0.6247 0.6616 0.6321 0.6533
Table XV. The average difference between the proportions of reduction in the total proba-
bility of undesirable states obtained by the best control gene g∗ and the predicted
control gene obtained by the influence method g˘ with various cost values.
Bias 0.3 0.4 0.5 0.6 0.7
(A) c=2 0.0098 0.0102 0.0120 0.0133 0.0144
(B) c=4 0.0103 0.0190 0.0151 0.0190 0.0115
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show the performance of the MFPT algorithm for higher values of c. Although the correct
prediction of the MFPT algorithm slightly degrades for higher values of the control cost c,
it still outperforms the influence method.
b. Approximation of the Optimal Control Policy
Once the best control gene g∗ is known, the corresponding MFPT control policy µˆγg∗ can be
used as an approximate solution to the optimal stochastic control problem. As previously
explained, the parameter γ depends on the ratio of the cost of control to the cost of unde-
sirable states. We numerically find the minimal value of the parameter γ for each control
cost so that on average Γoptg∗ > Γ
MFPT(γ)
g∗ . It is shown that the average of ∆P
opt
g∗ −∆P
MFPT(γ)
g∗
over random intervention problems with fixed control cost is small. We generate random
PBNs following the procedure explained earlier. The cost of undesirable states is fixed. For
the PBNs with identical bias mean, we formulate the intervention problems with various
costs of control, which are varied such that the ratio of the cost of control to the cost of
undesirable states changes from 0 to 1. For PBNs with each bias mean and cost of control,
we compute the averages of ∆P optg∗ and Γ
opt
g∗ . The averages are taken over 1000 intervention
problems with PBNs whose bias means are fixed. Similarly, the averages of ∆PMFPT(γ)g∗ and
Γ
MFPT(γ)
g∗ are found. Furthermore, we compute the average of these averages over all bias
means. The parameter γ is determined such that ΓMFPT(γ)g∗ < Γ
opt
g∗ . For each given control
cost, we show the behavior of ∆P optg∗ and Γ
opt
g∗ (∆PMFPTg∗ and ΓMFPT(γ)g∗ ). As seen in Fig. 20a,
both ∆PMFPT(γ)g∗ and ∆P
opt
g∗ decrease when the ratio of the cost of control to the cost of un-
desirable states increases. We observe that on average the difference between ∆P optg∗ and
∆P
MFPT(γ)
g∗ is less than 0.02. As Fig. 20b shows, the probability of the execution of control
for both policies decreases as the cost of control increases. Table XVI shows the relation of
the parameter γ with the ratio of the cost of control to the cost of undesirable states found
in the above experiment.
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Fig. 20. a) Average of ∆PMFPT(γ)g∗ and ∆P optg∗ b) Average of ΓMFPT(γ)g∗ and Γoptg∗ . Horizontal axis
shows the ratio of the cost of control to the cost of undesirable states. Values of γ
are chosen from Table XVI.
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Table XVI. Value of the parameter γ as a function of the ratio of the cost of control to the
cost of undesirable states
Ratio of costs 0 0.2 0.4 0.6 0.8 1
γ 0 0.29 0.61 0.91 1.5 1.94
Table XVII. Conservative value of the parameter γ as a function of the ratio of the cost of
control to the cost of undesirable states
Ratio of costs 0 0.2 0.4 0.6 0.8 1
γ 0.05 0.5 0.9 1.1 1.9 2.3
Since the values in Table XVI are found from random PBNs, one can have a conser-
vative approach and choose the parameter γ to be greater than the proposed values. To this
end, ΓMFPT(γ)g∗ is smaller than Γ
opt
g∗ in each intervention problem. Fig. 21 and Table XVII
show the outcomes of the same experiment explained earlier when the parameter γ is cho-
sen conservatively. In all the intervention problems of this experiment, ΓMFPT(γ)g∗ < Γ
opt
g∗ and
the deviation of ∆PMFPT(γ)g∗ from ∆P
opt
g∗ is smaller than 0.04.
c. Controllability
To corroborate that the MFPT algorithm can be employed to determine the controllability
of a network, we consider the results in Fig. 20. In this figure, when the cost of control
is zero (γ = 0), ∆PMFPT(0)g∗ is an accurate approximation of the ∆P optg∗ . The average of the
difference ∆PMFPT(0)g∗ −∆P
opt
g∗ has a negligible value equal to 0.0007.
d. Model-free Intervention
To compare the performance of the model-free MFPT control algorithm with an optimal
control algorithm, where the latter includes estimation of the transition probability matrix,
we generate synthetic time-course data for 100, 000 time-steps from an existing model. Us-
ing the synthetic time-course data, we estimate the mean first-passage times after each 10k
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Fig. 21. a) Average of ∆PMFPT(γ)g∗ and ∆P optg∗ b) Average of ΓMFPT(γ)g∗ and Γoptg∗ . Horizontal axis
shows the ratio of the cost of control to the cost of undesirable states. Values of γ
are chosen conservatively from Table XVII.
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time-steps, for k = 2, . . . , 5, and fix the cost of control to have the value 1. As the duration
of estimating the mean first-passage times increases, ∆PMFPT(γ)g∗ approaches ∆P
opt
g∗ . Fig. 22
shows the average of |∆P optg∗ − ∆P
MFPT(γ)
g∗ |, where ∆P
opt
g∗ is obtained from the original
transition probabilities, with various estimating durations over 1000 trials. For an optimal
control policy based on the Markov chain estimated from the data, we denote the shift in
the steady-state distribution by ∆̂P optg∗ . Fig. 22 shows the average of |∆P
opt
g∗ − ∆̂P
opt
g∗ | with
various estimating durations over 1000 trials. The graphs clearly demonstrate the superior
performance of the model-free approach using the MFPT algorithm. In particular, for lower
numbers of observations, which correspond better to feasible experimental conditions, es-
timating the Markov chain yields poor results, whereas the MFPT approximation performs
quite well.
Fig. 22. Average of |∆P opt-∆̂P opt| (solid) and |∆P opt -∆PMFPT(γ)| (dash) over 1000 trials as
a function of the logarithm of estimation duration.
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2. Melanoma Gene Expression
In this section, we compare the performances of optimal and MFPT control polices in the
context of a gene network developed from steady-state data. Based on our objective, the
cost of control is assumed to be 1 and the states are assigned penalties according to the
following scheme:
r(u, j) =

0 if u = 0 and j ∈ D,
5 if u = 0 and j ∈ U ,
1 if u = 1 and j ∈ D,
6 if u = 1 and j ∈ U ,
which is the same cost structure as assumed in [11]. Since our objective is to down-regulate
the WNT5A gene, a higher penalty is assigned for destination states having WNT5A up-
regulated. Also, for a given WNT5A status for the destination state, a higher penalty is
assigned when the control is active versus when it is not. Note that the cost scheme reflects
our objective; in practice, the actual values would have to be assigned by a physician ac-
cording to his or her understanding of the disease. Optimal and MFPT control policies are
found for the melanoma-related PBN. Table XVIII summarizes the amount of the shift in
the total probability mass of the undesirable states obtained by each of these two methods.
We apply the influence method to predict the best control gene. We then compare the pre-
diction of the influence method with the prediction of the MFPT algorithm and the optimal
gene determined directly by the solution of a dynamic programming algorithm. Table XIX
shows the ranking of the genes based on: direct solution of the optimal control policy, the
MFPT algorithm, and the influence method. The MFPT method not only predicts the best
control gene, but it also exactly predicts the ranking of the control genes. As Table XIX
shows, the influence method does a poor job on predicting the best control gene.
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Table XVIII. ∆P optg and ∆P
MFPT(γ)
g for all control genes g in the melanoma case-study
Gene (g) STC2 Synuclein HADHB MART1 PHOC MMP3 RET1 S100P pirin
∆P optg 0.0733 0.0892 0.1453 0.1104 0.2325 0.1121 0.0529 0.1032 0.1305
∆P
MFPT(γ)
g 0.0721 0.0824 0.1437 0.1071 0.2312 0.1120 0.0507 0.1021 0.1272
Table XIX. Comparison of the control gene ranking based on ∆P optg∗ ,∆P
opt
gˆ , and ∆P
opt
g˘
Rank 1 2 3 4 5 6 7 8 9
Optimal PHOC HADHB pirin MMP3 MART1 S100P Synuclein STC2 RET1
MFPT PHOC HADHB pirin MMP3 MART1 S100P Synuclein STC2 RET1
Influence MMP3 HADHB MART1 S100P STC2 pirin PHOC RET1 Synuclein
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CHAPTER VII
CONCLUSION
In this work, we discussed several approaches that have been recently developed for ad-
dressing the issue of inference and intervention in gene regulatory networks. The results
reported indicate that significant progress has been made in this area. Our current collab-
orations with the Translational Genomics Research Institute (TGen) aims at validating the
efficacy of mathematically derived intervention strategies for controlling the pathological
behavior of cancerous cells. This research has the potential to dramatically impact future
medical practice. Engineering-based interventions that achieve cellular behavior alteration
will enhance current cancer treatment and lead to the development of personalized cancer
therapies. In the following, I outline some promising research directions for the future.
The feasibility of the proposed project critically depends on a genuine collaboration be-
tween biologists, physicians, and engineers
Effective Intervention in Heterogeneous Metastatic Cells
Metastasis, the spread of cancerous cells from the primary tumor to distant organs, and
their relentless growth, is the most fearsome aspect of cancer. Despite significant improve-
ments in diagnosis, surgical techniques, and general patient care, most deaths from cancer
are due to metastases that are resistant to conventional therapies. The main barrier to the
treatment of metastases is the biological heterogeneity of cancer cells in the primary tumor
and in metastases. Continual empiricism in the treatment of cancer metastasis is unlikely to
produce significant improvements in cancer therapy. Therefore, understanding the patho-
genesis of metastasis at the systemic level is an important goal of cancer research.
By the time of initial diagnosis, malignant tumors already contain multiple cell sub-
populations with diverse biological heterogeneity. The heterogeneous nature of the re-
106
sponse of malignant tumor cell sub-populations to cytotoxic drugs makes it unlikely that a
single treatment regimen will be able to kill all the cells in a tumor. The goal of this research
project is to devise therapeutic methods to maximally eradicate heterogenous metastatic
cells. To achieve this goal, we envision a number of objectives for which both models and
experiments must be advanced.
• Detect major cell subpopulations in a tumor.
• Estimate the growth rate of each cell subpopulation.
• Devise effective therapeutic methods to halt uncontrolled cell-growth in cell subpop-
ulations.
• Devise adaptive strategy to eradicate various cell subpopulations.
The current approach to cancer therapy is to experiment with one drug after the other
until one drug works for a particular patient or all available options get exhausted. If this
proposed research is successful, it should be possible to study a cancer patient’s tumor in
vitro and predict apriori which treatment or set of treatments is most likely to work for
that patient. This should enhance the current trial and error approach to cancer therapy and
thereby considerably improve the quality of life and therapy outcome for cancer patients.
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